Laboratory Corp. Of America Holdings. (LH) NEW YORK STOCK EXCHANGE INC.

$239.07 -2.30 (-0.95%)

Market Cap: $21.39B

As of 11/28/22 10:54 AM EST. Market open.

(LH)

Laboratory Corp. Of America Holdings. (LH) NEW YORK STOCK EXCHANGE INC.

$239.07 -2.30 (-0.95%)

Market Cap: $21.39B

As of 11/28/22 10:54 AM EST. Market open.

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, company provides insights and accelerates innovations to improve health and improve lives. With more than 70,000 employees, ... read more

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, company provides insights and accelerates innovations to improve health and improve lives. With more than 70,000 employees, Labcorp serves clients in more than 100 countries. Labcorp reported revenue of $14 billion in FY2020. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Dental Laboratories
CEO
Adam Schechter
Full Time Employees
72,400
CEO Compensation (Base)
$1.18M
CEO Compensation (Total)
$12.26M
URL
Address
358 S Main St, North Carolina, Burlington, 27215-5837.
Sector
Manufacturing
Industry
Dental Laboratories
CEO
Adam Schechter
Full Time Employees
72,400
CEO Compensation (Base)
$1.18M
CEO Compensation (Total)
$12.26M
Address
358 S Main St, North Carolina, Burlington, 27215-5837.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$240.22
Previous Close
$241.37
Days Range
$238.63 - $241.38
52 week range
$199.73 - $314.45
Volume
74,048
Avg. Volume (30 days)
857,125
Market Cap
$21.39B
Dividend Yield
0.89%
P/E
12.18
Shares Outstanding
88,600,000
Open
$240.22
Previous Close
$241.37
Days Range
$238.63 - $241.38
52 week range
$199.73 - $314.45
Volume
74,048
Avg. Volume (30 days)
857,125
Market Cap
$21.39B
Dividend Yield
0.89%
P/E
12.18
Shares Outstanding
88,600,000

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR LABORATORY CORP. OF AMERICA HOLDINGS
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Schroeder Mark S EVP, President-Diagnostics Lab Nov 08, 2022 Sale $232.67 1,116 259,660 6,687 Nov 10, 2022, 08:40 AM
Schroeder Mark S EVP, President-Diagnostics Lab Nov 07, 2022 Option Exercise $233.77 894 208,990 7,803 Nov 08, 2022, 04:27 PM
Caveney Brian J EVP, President of Diagnostics Nov 07, 2022 Option Exercise $233.77 894 208,990 15,398 Nov 08, 2022, 04:20 PM
EISENBERG GLENN A Chief Financial Officer, EVP Nov 01, 2022 Option Exercise $222.56 5,348 1,190,251 33,842 Nov 03, 2022, 05:04 PM
Schechter Adam H President & CEO Nov 01, 2022 Option Exercise $222.56 893 198,746 17,588 Nov 03, 2022, 05:01 PM
Kirchgraber Paul R CEO, Covance Drug Development Nov 01, 2022 Option Exercise $222.56 892 198,524 13,030 Nov 03, 2022, 05:00 PM
EISENBERG GLENN A Chief Financial Officer, EVP Sep 26, 2022 Sale $210.62 25,000 5,265,576 46,531 Sep 28, 2022, 09:12 AM
Caveney Brian J EVP, President of Diagnostics Sep 07, 2022 Buy $231.20 44 10,173 14,282 Sep 13, 2022, 11:39 AM
EISENBERG GLENN A Chief Financial Officer, EVP Aug 03, 2022 Option Exercise $147.12 32,100 4,722,543 84,258 Aug 05, 2022, 09:52 AM
EISENBERG GLENN A Chief Financial Officer, EVP Aug 03, 2022 Sale $253.94 32,100 8,151,450 72,996 Aug 05, 2022, 09:52 AM
Wilkinson Peter J SVP, Chief Accounting Officer Aug 01, 2022 Option Exercise $257.94 23 5,933 1,914 Aug 03, 2022, 11:54 AM
Wilkinson Peter J SVP, Chief Accounting Officer Aug 01, 2022 Option Exercise $146.59 767 112,435 2,654 Aug 03, 2022, 11:54 AM
Wilkinson Peter J SVP, Chief Accounting Officer Aug 01, 2022 Sale $258.40 2,576 665,635 1,897 Aug 03, 2022, 11:54 AM
Caveney Brian J EVP, President of Diagnostics Jun 07, 2022 Buy $242.19 42 10,172 14,172 Jun 14, 2022, 08:46 AM
Schroeder Mark S EVP, President-Diagnostics Lab Mar 29, 2022 Sale $277.11 2,356 652,871 6,605 Mar 31, 2022, 10:24 AM
van der Vaart Sandra D EVP, Chief Legal Officer Mar 29, 2022 Sale $277.11 2,449 678,642 5,287 Mar 31, 2022, 10:20 AM
BERBERIAN LANCE EVP, CIO & CTO Mar 28, 2022 Option Exercise $276.42 2,360 652,351 19,502 Mar 29, 2022, 12:09 PM
Caveney Brian J EVP, President of Diagnostics Mar 28, 2022 Option Exercise $276.42 1,883 520,499 14,130 Mar 29, 2022, 12:07 PM
EISENBERG GLENN A Chief Financial Officer, EVP Mar 28, 2022 Option Exercise $276.42 6,286 1,737,576 52,158 Mar 29, 2022, 12:05 PM
Kirchgraber Paul R CEO, Covance Drug Development Mar 28, 2022 Option Exercise $276.42 1,648 455,540 11,915 Mar 29, 2022, 12:04 PM
Schroeder Mark S EVP, President-Diagnostics Lab Mar 28, 2022 Option Exercise $276.42 1,885 521,052 8,961 Mar 29, 2022, 12:03 PM
van der Vaart Sandra D EVP, Chief Legal Officer Mar 28, 2022 Option Exercise $276.42 1,792 495,345 7,736 Mar 29, 2022, 12:02 PM
Wilkinson Peter J SVP, Chief Accounting Officer Mar 28, 2022 Option Exercise $276.42 915 252,924 3,696 Mar 29, 2022, 12:00 PM
Williams R Sanders Director Mar 25, 2022 Sale $272.98 572 156,145 6,431 Mar 29, 2022, 09:46 AM
Summy Amy B. EVP, Chief Marketing Officer Mar 10, 2022 Sale $262.21 249 65,290 250 Mar 14, 2022, 04:36 PM
NEUPERT PETER M Director Feb 16, 2022 Buy $263.66 3,500 922,815 10,254 Feb 18, 2022, 08:46 PM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 15, 2022 Sale $273.98 207 56,714 6,605 Feb 17, 2022, 03:05 PM
van der Vaart Sandra D EVP, Chief Legal Officer Feb 15, 2022 Sale $273.98 207 56,714 5,287 Feb 17, 2022, 03:03 PM
Wilkinson Peter J SVP, Chief Accounting Officer Feb 14, 2022 Option Exercise $272.68 261 71,169 1,989 Feb 15, 2022, 04:51 PM
Caveney Brian J EVP, President of Diagnostics Feb 14, 2022 Option Exercise $272.68 778 212,145 12,466 Feb 15, 2022, 04:48 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 14, 2022 Option Exercise $272.68 277 75,532 44,300 Feb 15, 2022, 04:43 PM
Kirchgraber Paul R CEO, Covance Drug Development Feb 14, 2022 Option Exercise $272.68 108 29,449 9,856 Feb 15, 2022, 04:42 PM
BERBERIAN LANCE EVP, CIO & CTO Feb 14, 2022 Option Exercise $272.68 799 217,871 16,657 Feb 15, 2022, 04:40 PM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 14, 2022 Option Exercise $272.68 77 20,996 6,812 Feb 15, 2022, 04:38 PM
van der Vaart Sandra D EVP, Chief Legal Officer Feb 14, 2022 Option Exercise $272.68 77 20,996 5,494 Feb 15, 2022, 04:37 PM
BERBERIAN LANCE EVP, CIO & CTO Feb 04, 2022 Option Exercise $277.48 109 30,245 14,643 Feb 08, 2022, 11:19 AM
Caveney Brian J EVP, President of Diagnostics Feb 04, 2022 Option Exercise $277.48 165 45,784 9,912 Feb 08, 2022, 11:18 AM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 04, 2022 Option Exercise $277.48 286 79,359 43,637 Feb 08, 2022, 11:16 AM
Kirchgraber Paul R CEO, Covance Drug Development Feb 04, 2022 Option Exercise $277.48 165 45,784 9,647 Feb 08, 2022, 11:13 AM
Schechter Adam H President & CEO Feb 04, 2022 Option Exercise $277.48 1,412 391,802 16,474 Feb 08, 2022, 11:10 AM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 04, 2022 Option Exercise $277.48 152 42,177 6,809 Feb 08, 2022, 11:08 AM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 07, 2022 Sale $277.38 204 56,586 6,605 Feb 08, 2022, 11:08 AM
Seltz Judith C EVP, CHRO Feb 04, 2022 Option Exercise $277.48 85 23,586 1,377 Feb 08, 2022, 11:06 AM
Summy Amy B. EVP, Chief Marketing Officer Feb 04, 2022 Option Exercise $277.48 83 23,031 499 Feb 08, 2022, 11:03 AM
van der Vaart Sandra D EVP, Chief Legal Officer Feb 04, 2022 Option Exercise $277.48 82 22,753 5,505 Feb 08, 2022, 11:01 AM
van der Vaart Sandra D EVP, Chief Legal Officer Feb 07, 2022 Sale $277.38 218 60,469 5,287 Feb 08, 2022, 11:01 AM
Wilkinson Peter J SVP, Chief Accounting Officer Feb 04, 2022 Option Exercise $277.48 53 14,706 1,183 Feb 08, 2022, 11:00 AM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 02, 2022 Option Exercise $273.18 121 33,055 6,562 Feb 04, 2022, 12:15 PM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 03, 2022 Sale $271.81 161 43,761 6,401 Feb 04, 2022, 12:15 PM
van der Vaart Sandra D EVP, Chief Legal Officer Feb 02, 2022 Option Exercise $273.18 64 17,484 5,459 Feb 04, 2022, 12:14 PM
van der Vaart Sandra D EVP, Chief Legal Officer Feb 03, 2022 Sale $271.81 172 46,751 5,287 Feb 04, 2022, 12:14 PM
Summy Amy B. EVP, Chief Marketing Officer Feb 02, 2022 Option Exercise $273.18 77 21,035 315 Feb 04, 2022, 09:45 AM
Kirchgraber Paul R CEO, Covance Drug Development Feb 02, 2022 Option Exercise $273.18 144 39,338 9,252 Feb 04, 2022, 09:44 AM
Seltz Judith C EVP, CHRO Feb 02, 2022 Option Exercise $273.18 76 20,762 1,182 Feb 04, 2022, 09:43 AM
Wilkinson Peter J SVP, Chief Accounting Officer Feb 02, 2022 Option Exercise $273.18 41 11,200 1,086 Feb 04, 2022, 09:42 AM
Caveney Brian J EVP, President of Diagnostics Feb 02, 2022 Option Exercise $273.18 147 40,157 9,517 Feb 04, 2022, 09:37 AM
Schechter Adam H President & CEO Feb 02, 2022 Option Exercise $273.18 803 219,364 14,379 Feb 04, 2022, 09:36 AM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 02, 2022 Option Exercise $273.18 236 64,470 42,953 Feb 04, 2022, 09:34 AM
BERBERIAN LANCE EVP, CIO & CTO Feb 02, 2022 Option Exercise $273.18 103 28,138 14,379 Feb 04, 2022, 09:33 AM
BELINGARD JEAN-LUC Director Feb 02, 2022 Option Exercise $273.18 78 21,308 16,262 Feb 04, 2022, 09:00 AM
Gilliland Dwight Gary Director Dec 15, 2021 Sale $302.26 500 151,128 6,395 Dec 17, 2021, 10:36 AM
Caveney Brian J EVP, President of Diagnostics Nov 05, 2021 Option Exercise $274.84 899 247,081 9,182 Nov 09, 2021, 02:49 PM
Schroeder Mark S EVP, President-Diagnostics Lab Nov 05, 2021 Option Exercise $274.84 899 247,081 6,240 Nov 09, 2021, 02:46 PM
Schechter Adam H President & CEO Nov 01, 2021 Option Exercise $288.78 886 255,859 12,409 Nov 03, 2021, 11:51 AM
EISENBERG GLENN A Chief Financial Officer, EVP Nov 01, 2021 Option Exercise $288.78 4,034 1,164,939 42,423 Nov 03, 2021, 11:49 AM
Kirchgraber Paul R CEO, Covance Drug Development Nov 01, 2021 Option Exercise $288.78 898 259,324 8,953 Nov 03, 2021, 11:47 AM
van der Vaart Sandra D EVP, Chief Legal Officer Sep 15, 2021 Option Exercise $84.86 4,500 381,870 9,765 Sep 17, 2021, 12:20 PM
van der Vaart Sandra D EVP, Chief Legal Officer Sep 15, 2021 Sale $296.78 4,500 1,335,510 5,265 Sep 17, 2021, 12:20 PM
Wilkinson Peter J SVP, Chief Accounting Officer Aug 02, 2021 Option Exercise $297.61 15 4,464 1,011 Aug 03, 2021, 04:16 PM
van der Vaart Sandra D EVP, Chief Legal Officer Jun 07, 2021 Option Exercise $84.86 4,500 381,870 9,737 Jun 09, 2021, 02:03 PM
van der Vaart Sandra D EVP, Chief Legal Officer Jun 07, 2021 Sale $266.56 4,500 1,199,520 5,237 Jun 09, 2021, 02:03 PM
BELINGARD JEAN-LUC Director May 03, 2021 Option Exercise $98.49 2,600 256,074 18,169 May 05, 2021, 10:48 AM
BELINGARD JEAN-LUC Director May 03, 2021 Sale $269.16 2,600 699,803 15,569 May 05, 2021, 10:48 AM
Kirchgraber Paul R CEO, Covance Drug Development Apr 03, 2021 Option Exercise $252.67 452 114,207 10,344 Apr 06, 2021, 12:18 PM
Schroeder Mark S EVP, President-Diagnostics Lab Mar 30, 2021 Sale $251.88 667 168,004 5,006 Apr 01, 2021, 08:32 AM
van der Vaart Sandra D EVP, Chief Legal Officer Mar 30, 2021 Sale $251.88 812 204,527 5,237 Apr 01, 2021, 08:32 AM
EISENBERG GLENN A Chief Financial Officer, EVP Mar 27, 2021 Option Exercise $251.58 3,595 904,430 37,433 Mar 30, 2021, 06:46 PM
BERBERIAN LANCE EVP, CIO & CTO Mar 27, 2021 Option Exercise $251.58 1,079 271,455 14,186 Mar 30, 2021, 06:45 PM
Caveney Brian J EVP, President of Diagnostics Mar 27, 2021 Option Exercise $251.58 1,079 271,455 8,001 Mar 30, 2021, 06:43 PM
Kirchgraber Paul R CEO, Covance Drug Development Mar 27, 2021 Option Exercise $251.58 790 198,748 9,786 Mar 30, 2021, 06:42 PM
Schroeder Mark S EVP, President-Diagnostics Lab Mar 27, 2021 Option Exercise $251.58 1,079 271,455 5,673 Mar 30, 2021, 06:41 PM
van der Vaart Sandra D EVP, Chief Legal Officer Mar 27, 2021 Option Exercise $251.58 687 172,835 6,049 Mar 30, 2021, 06:40 PM
Wilkinson Peter J SVP, Chief Accounting Officer Feb 12, 2021 Option Exercise $238.26 263 62,662 1,127 Feb 19, 2021, 02:17 PM
Wilkinson Peter J SVP, Chief Accounting Officer Feb 18, 2021 Option Exercise $157.09 2,166 340,251 2,660 Feb 19, 2021, 02:17 PM
Wilkinson Peter J SVP, Chief Accounting Officer Feb 18, 2021 Sale $241.51 2,317 559,589 343 Feb 19, 2021, 02:17 PM
van der Vaart Sandra D EVP, Chief Legal Officer Feb 12, 2021 Option Exercise $238.26 158 37,645 4,634 Feb 17, 2021, 04:28 PM
van der Vaart Sandra D EVP, Chief Legal Officer Feb 16, 2021 Sale $236.55 208 49,202 4,531 Feb 17, 2021, 04:28 PM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 12, 2021 Option Exercise $238.26 142 33,833 4,527 Feb 17, 2021, 04:27 PM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 16, 2021 Sale $237.06 188 44,567 4,424 Feb 17, 2021, 04:27 PM
Kirchgraber Paul R CEO, Covance Drug Development Feb 12, 2021 Option Exercise $238.26 180 42,887 8,472 Feb 17, 2021, 04:25 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 12, 2021 Option Exercise $238.26 512 121,989 32,986 Feb 17, 2021, 04:23 PM
Caveney Brian J EVP, President of Diagnostics Feb 12, 2021 Option Exercise $238.26 854 203,474 6,667 Feb 17, 2021, 04:22 PM
BERBERIAN LANCE EVP, CIO & CTO Feb 12, 2021 Option Exercise $238.26 873 208,001 12,852 Feb 17, 2021, 04:21 PM
Schechter Adam H President & CEO Feb 04, 2021 Option Exercise $223.78 1,028 230,046 11,288 Feb 08, 2021, 03:48 PM
Wilkinson Peter J SVP, Chief Accounting Officer Feb 04, 2021 Option Exercise $223.78 53 11,860 523 Feb 08, 2021, 03:46 PM
van der Vaart Sandra D EVP, Chief Legal Officer Feb 04, 2021 Option Exercise $223.78 83 18,574 4,328 Feb 08, 2021, 03:43 PM
van der Vaart Sandra D EVP, Chief Legal Officer Feb 05, 2021 Sale $225.85 109 24,618 4,219 Feb 08, 2021, 03:43 PM
Summy Amy B. EVP, Chief Marketing Officer Feb 04, 2021 Option Exercise $223.78 94 21,035 172 Feb 08, 2021, 03:42 PM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 04, 2021 Option Exercise $223.78 154 34,462 4,355 Feb 08, 2021, 03:40 PM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 05, 2021 Sale $225.85 203 45,848 4,152 Feb 08, 2021, 03:40 PM
Kirchgraber Paul R CEO, Covance Drug Development Feb 04, 2021 Option Exercise $223.78 187 41,847 8,071 Feb 08, 2021, 03:39 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 04, 2021 Option Exercise $223.78 306 68,477 31,778 Feb 08, 2021, 03:36 PM
Caveney Brian J EVP, President of Diagnostics Feb 04, 2021 Option Exercise $223.78 190 42,518 4,651 Feb 08, 2021, 03:35 PM
BERBERIAN LANCE EVP, CIO & CTO Feb 04, 2021 Option Exercise $223.78 131 29,315 10,785 Feb 08, 2021, 03:34 PM
Seltz Judith C EVP, CHRO Feb 04, 2021 Option Exercise $223.78 96 21,483 915 Feb 08, 2021, 03:33 PM
BELINGARD JEAN-LUC Director Feb 04, 2021 Option Exercise $223.78 99 22,154 15,569 Feb 08, 2021, 03:14 PM
Williams R Sanders Director Jan 26, 2021 Option Exercise $98.49 1,300 128,037 5,246 Jan 28, 2021, 12:11 PM
Schroeder Mark S EVP, President-Diagnostics Lab Nov 06, 2020 Sale $214.59 588 126,179 3,949 Nov 10, 2020, 10:48 AM
Caveney Brian J EVP, President of Diagnostics Nov 05, 2020 Option Exercise $214.42 886 189,976 4,221 Nov 09, 2020, 09:21 AM
Schroeder Mark S EVP, President-Diagnostics Lab Nov 05, 2020 Option Exercise $214.42 835 179,041 4,537 Nov 09, 2020, 09:19 AM
Kirchgraber Paul R CEO, Covance Drug Development Nov 04, 2020 Sale $214.14 1,500 321,204 7,698 Nov 06, 2020, 09:06 AM
EISENBERG GLENN A Chief Financial Officer, EVP Nov 02, 2020 Option Exercise $207.23 4,034 835,966 31,114 Nov 04, 2020, 05:47 PM
Schechter Adam H President & CEO Nov 02, 2020 Option Exercise $207.23 885 183,399 8,810 Nov 04, 2020, 05:43 PM
Kirchgraber Paul R CEO, Covance Drug Development Nov 02, 2020 Option Exercise $207.23 895 185,471 9,198 Nov 04, 2020, 05:40 PM
Caveney Brian J EVP, President of Diagnostics Sep 25, 2020 Option Exercise $180.99 289 52,306 3,097 Sep 29, 2020, 01:42 PM
Williams R Sanders Director Jul 08, 2020 Option Exercise $98.49 1,300 128,037 6,395 Jul 10, 2020, 04:25 PM
Williams R Sanders Director Jul 08, 2020 Sale $173.12 1,300 225,056 5,095 Jul 10, 2020, 04:25 PM
van der Vaart Sandra D EVP, Chief Legal Officer Jul 02, 2020 Sale $170.00 435 73,950 4,044 Jul 07, 2020, 09:38 AM
van der Vaart Sandra D EVP, Chief Legal Officer Jun 24, 2020 Sale $160.33 872 139,808 4,915 Jun 26, 2020, 10:06 AM
KING DAVID P Director May 05, 2020 Sale $160.00 31,250 5,000,000 312,554 May 07, 2020, 12:05 PM
Seltz Judith C EVP, CHRO Mar 10, 2020 Buy $168.56 330 55,625 580 May 04, 2020, 10:18 AM
Seltz Judith C EVP, CHRO Feb 28, 2020 Buy $174.94 250 43,735 250 May 04, 2020, 10:18 AM
Kirchgraber Paul R CEO, Covance Drug Development Apr 03, 2020 Option Exercise $113.31 372 42,151 8,087 Apr 07, 2020, 04:21 PM
KING DAVID P Director Mar 30, 2020 Option Exercise $131.95 24,583 3,243,727 343,804 Apr 01, 2020, 02:40 PM
van der Vaart Sandra D EVP, Chief Legal Officer Mar 30, 2020 Option Exercise $131.95 1,106 145,937 5,351 Apr 01, 2020, 02:39 PM
EISENBERG GLENN A Chief Financial Officer, EVP Mar 30, 2020 Option Exercise $131.95 5,787 763,595 26,124 Apr 01, 2020, 02:33 PM
Kirchgraber Paul R CEO, Covance Drug Development Mar 30, 2020 Option Exercise $131.95 1,014 133,797 7,449 Apr 01, 2020, 02:29 PM
Schroeder Mark S EVP, President-Diagnostics Lab Mar 30, 2020 Option Exercise $131.95 1,153 152,138 3,213 Apr 01, 2020, 02:28 PM
BERBERIAN LANCE EVP, CIO & CTO Mar 30, 2020 Option Exercise $131.95 1,695 223,655 10,543 Apr 01, 2020, 02:23 PM
Wilkinson Peter J SVP, Chief Accounting Officer Feb 21, 2020 Sale $189.65 297 56,326 297 Feb 25, 2020, 12:59 PM
BELINGARD JEAN-LUC Director Feb 19, 2020 Option Exercise $77.19 3,100 239,289 41,161 Feb 21, 2020, 03:52 PM
BELINGARD JEAN-LUC Director Feb 19, 2020 Sale $189.76 26,479 5,024,750 14,682 Feb 21, 2020, 03:52 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 12, 2020 Option Exercise $187.51 512 96,005 18,966 Feb 14, 2020, 05:32 PM
van der Vaart Sandra D SVP, Global General Counsel Feb 12, 2020 Option Exercise $187.51 158 29,627 2,944 Feb 14, 2020, 05:11 PM
van der Vaart Sandra D SVP, Global General Counsel Feb 13, 2020 Sale $188.49 208 39,206 2,839 Feb 14, 2020, 05:11 PM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 12, 2020 Option Exercise $187.51 142 26,626 674 Feb 14, 2020, 05:07 PM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 13, 2020 Sale $188.49 188 35,436 589 Feb 14, 2020, 05:07 PM
BERBERIAN LANCE SVP, Chief Information Officer Feb 12, 2020 Option Exercise $187.51 872 163,509 8,358 Feb 14, 2020, 04:11 PM
Caveney Brian J EVP, President of Diagnostics Feb 12, 2020 Option Exercise $187.51 866 162,384 2,326 Feb 14, 2020, 03:51 PM
Wilkinson Peter J SVP, Chief Accounting Officer Feb 12, 2020 Option Exercise $187.51 272 51,003 594 Feb 14, 2020, 03:50 PM
Kirchgraber Paul R CEO, Covance Drug Development Feb 12, 2020 Option Exercise $187.51 159 29,814 5,061 Feb 14, 2020, 03:48 PM
KING DAVID P Director Feb 12, 2020 Option Exercise $187.51 3,280 615,033 313,392 Feb 14, 2020, 03:42 PM
BELINGARD JEAN-LUC Director Feb 12, 2020 Option Exercise $187.51 123 23,064 38,061 Feb 14, 2020, 03:30 PM
Williams R Sanders Director Feb 13, 2020 Sale $188.49 1,227 231,277 5,095 Feb 14, 2020, 03:08 PM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 07, 2020 Option Exercise $182.33 82 14,951 408 Feb 11, 2020, 01:47 PM
Schroeder Mark S EVP, President-Diagnostics Lab Feb 10, 2020 Sale $181.99 108 19,655 300 Feb 11, 2020, 01:47 PM
van der Vaart Sandra D SVP, Global General Counsel Feb 07, 2020 Option Exercise $182.33 101 18,415 2,662 Feb 11, 2020, 01:45 PM
van der Vaart Sandra D SVP, Global General Counsel Feb 10, 2020 Sale $181.99 133 24,205 2,529 Feb 11, 2020, 01:45 PM
Kirchgraber Paul R CEO, Covance Drug Development Feb 07, 2020 Option Exercise $182.33 103 18,780 4,641 Feb 11, 2020, 01:43 PM
KING DAVID P Director Feb 07, 2020 Option Exercise $182.33 1,252 228,277 308,923 Feb 11, 2020, 01:42 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 07, 2020 Option Exercise $182.33 295 53,787 17,758 Feb 11, 2020, 01:39 PM
BERBERIAN LANCE SVP, Chief Information Officer Feb 07, 2020 Option Exercise $182.33 103 18,780 6,291 Feb 11, 2020, 01:38 PM
BELINGARD JEAN-LUC Director Dec 04, 2019 Option Exercise $171.82 327 56,185 36,957 Dec 06, 2019, 03:07 PM
KING DAVID P President & CEO Oct 28, 2019 Sale $165.40 30,177 4,991,217 328,676 Oct 30, 2019, 05:25 PM
ANDERSON KERRII B Director Sep 23, 2019 Option Exercise $98.49 2,600 256,074 20,533 Sep 25, 2019, 01:40 PM
ANDERSON KERRII B Director Sep 23, 2019 Sale $171.85 2,600 446,810 17,933 Sep 25, 2019, 01:40 PM
Uthgenannt Lisa J Chief Human Resources Officer Sep 04, 2019 Option Exercise $130.60 2,466 322,060 7,126 Sep 06, 2019, 09:54 AM
Uthgenannt Lisa J Chief Human Resources Officer Sep 04, 2019 Sale $168.59 2,466 415,743 4,660 Sep 06, 2019, 09:54 AM
BERBERIAN LANCE SVP, Chief Information Officer Aug 30, 2019 Sale $169.80 5,902 1,002,172 6,097 Sep 04, 2019, 09:04 AM
Williams R Sanders Director Aug 05, 2019 Sale $162.91 500 81,455 6,886 Aug 07, 2019, 11:40 AM
EISENBERG GLENN A Chief Financial Officer, EVP Jul 08, 2019 Sale $176.75 5,563 983,260 17,059 Jul 10, 2019, 09:03 AM
van der Vaart Sandra D SVP, Global General Counsel Jul 08, 2019 Sale $176.75 2,328 411,474 2,328 Jul 10, 2019, 09:02 AM
ANDERSON KERRII B Director Jun 20, 2019 Option Exercise $77.19 3,100 239,289 22,233 Jun 21, 2019, 03:26 PM
ANDERSON KERRII B Director Jun 20, 2019 Sale $170.00 3,100 527,000 19,133 Jun 21, 2019, 03:26 PM
EISENBERG GLENN A Chief Financial Officer, EVP Jun 07, 2019 Sale $167.40 10,000 1,673,970 28,366 Jun 11, 2019, 06:16 PM
Williams R Sanders Director May 06, 2019 Sale $162.20 500 81,100 7,386 May 08, 2019, 08:21 AM
MITTELSTAEDT ROBERT E JR Director May 03, 2019 Option Exercise $64.42 3,700 238,354 18,909 May 07, 2019, 11:00 AM
MITTELSTAEDT ROBERT E JR Director May 03, 2019 Sale $166.30 3,700 615,310 15,209 May 07, 2019, 11:00 AM
Uthgenannt Lisa J Chief Human Resources Officer May 02, 2019 Sale $164.00 4,000 656,000 4,638 May 06, 2019, 08:45 AM
Ratliff John D CEO, Covance Drug Development Apr 03, 2019 Option Exercise $156.68 1,084 169,841 16,941 Apr 05, 2019, 12:01 PM
KING DAVID P President & CEO Apr 01, 2019 Option Exercise $154.79 41,311 6,394,529 297,387 Apr 03, 2019, 05:30 PM
EISENBERG GLENN A Chief Financial Officer, EVP Apr 01, 2019 Option Exercise $154.79 10,013 1,549,912 32,622 Apr 03, 2019, 05:29 PM
van der Vaart Sandra D SVP, Global General Counsel Apr 01, 2019 Option Exercise $154.79 1,782 275,836 4,656 Apr 03, 2019, 05:27 PM
Dodson Edward T Principal Accounting Officer Apr 01, 2019 Option Exercise $154.79 1,779 275,371 13,663 Apr 03, 2019, 05:24 PM
Uthgenannt Lisa J Chief Human Resources Officer Apr 01, 2019 Option Exercise $154.79 3,236 500,900 8,638 Apr 03, 2019, 05:20 PM
BERBERIAN LANCE SVP, Chief Information Officer Apr 01, 2019 Option Exercise $154.79 2,287 354,005 11,999 Apr 03, 2019, 05:18 PM
BELINGARD JEAN-LUC Director Feb 12, 2019 Option Exercise $146.59 104 15,245 34,013 Feb 14, 2019, 05:01 PM
BELINGARD JEAN-LUC Director Feb 12, 2019 Option Exercise $64.42 3,700 238,354 36,779 Feb 14, 2019, 05:01 PM
BELINGARD JEAN-LUC Director Feb 12, 2019 Sale $146.06 3,700 540,407 33,079 Feb 14, 2019, 05:01 PM
KING DAVID P President & CEO Feb 12, 2019 Option Exercise $146.59 1,571 230,293 246,281 Feb 14, 2019, 04:44 PM
Williams R Sanders Director Feb 13, 2019 Sale $147.00 1,038 152,586 7,886 Feb 14, 2019, 04:18 PM
Dodson Edward T Principal Accounting Officer Feb 12, 2019 Option Exercise $146.59 54 7,916 9,912 Feb 14, 2019, 04:13 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 12, 2019 Option Exercise $146.59 64 9,382 28,823 Feb 14, 2019, 04:10 PM
Ratliff John D CEO, Covance Drug Development Feb 12, 2019 Option Exercise $146.59 654 95,870 15,601 Feb 14, 2019, 04:08 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 12, 2019 Option Exercise $146.59 232 34,009 20,235 Feb 14, 2019, 04:05 PM
BERBERIAN LANCE SVP, Chief Information Officer Feb 12, 2019 Option Exercise $146.59 70 10,261 8,756 Feb 14, 2019, 04:02 PM
Caveney Brian J SVP, Chief Medical Officer Feb 12, 2019 Option Exercise $146.59 82 12,020 151 Feb 14, 2019, 03:59 PM
Uthgenannt Lisa J Chief Human Resources Officer Feb 12, 2019 Option Exercise $146.59 103 15,099 4,489 Feb 14, 2019, 03:58 PM
Uthgenannt Lisa J Chief Human Resources Officer Feb 11, 2019 Option Exercise $144.29 240 34,630 4,336 Feb 13, 2019, 12:22 PM
Dodson Edward T Principal Accounting Officer Feb 11, 2019 Option Exercise $144.29 124 17,892 9,770 Feb 13, 2019, 12:18 PM
KING DAVID P President & CEO Feb 11, 2019 Option Exercise $144.29 2,980 429,984 244,339 Feb 13, 2019, 12:11 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 11, 2019 Option Exercise $144.29 143 20,633 28,654 Feb 13, 2019, 12:09 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 11, 2019 Option Exercise $144.29 1,449 209,076 19,687 Feb 13, 2019, 12:05 PM
BERBERIAN LANCE SVP, Chief Information Officer Feb 11, 2019 Option Exercise $144.29 1,037 149,629 8,593 Feb 13, 2019, 12:00 PM
Ratliff John D CEO, Covance Drug Development Feb 11, 2019 Option Exercise $144.29 1,973 284,684 14,792 Feb 13, 2019, 11:55 AM
Ratliff John D CEO, Covance Drug Development Feb 07, 2019 Option Exercise $147.46 556 81,988 10,665 Feb 11, 2019, 07:59 PM
KING DAVID P President & CEO Feb 07, 2019 Option Exercise $147.46 1,254 184,915 239,775 Feb 11, 2019, 07:56 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 07, 2019 Option Exercise $147.46 297 43,796 16,259 Feb 11, 2019, 07:53 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 07, 2019 Option Exercise $147.46 82 12,092 28,277 Feb 11, 2019, 07:51 PM
Dodson Edward T Principal Accounting Officer Feb 07, 2019 Option Exercise $147.46 68 10,027 9,444 Feb 11, 2019, 07:48 PM
Uthgenannt Lisa J Chief Human Resources Officer Feb 07, 2019 Option Exercise $147.46 148 21,824 3,972 Feb 11, 2019, 07:46 PM
BERBERIAN LANCE SVP, Chief Information Officer Feb 07, 2019 Option Exercise $147.46 104 15,336 6,133 Feb 11, 2019, 07:44 PM
Williams R Sanders Director Nov 27, 2018 Sale $162.14 350 56,749 7,886 Nov 29, 2018, 10:00 AM
ANDERSON KERRII B Director Nov 05, 2018 Option Exercise $64.42 3,700 238,354 21,795 Nov 07, 2018, 10:54 AM
ANDERSON KERRII B Director Nov 05, 2018 Sale $163.29 3,700 604,162 18,095 Nov 07, 2018, 10:54 AM
Gary M. Huff CEO, LabCorp Diagnostics Sep 04, 2018 Option Exercise $169.15 69 11,671 1,850 Sep 06, 2018, 10:21 AM
Dodson Edward T Principal Accounting Officer Jun 06, 2018 Option Exercise $84.86 13,000 1,103,180 22,113 Jun 08, 2018, 11:11 AM
Dodson Edward T Principal Accounting Officer Jun 06, 2018 Sale $183.35 13,000 2,383,563 9,113 Jun 08, 2018, 11:11 AM
Uthgenannt Lisa J Chief Human Resources Officer Jun 04, 2018 Sale $182.10 4,500 819,450 3,755 Jun 06, 2018, 02:59 PM
Gilliland Dwight Gary Director May 31, 2018 Sale $181.29 1,263 228,967 4,637 Jun 04, 2018, 04:17 PM
BERBERIAN LANCE SVP, Chief Information Officer May 31, 2018 Sale $182.30 5,500 1,002,672 6,255 Jun 04, 2018, 04:16 PM
Gary M. Huff CEO, LabCorp Diagnostics May 30, 2018 Sale $182.50 1,610 293,823 1,610 Jun 01, 2018, 08:15 AM
EISENBERG GLENN A Chief Financial Officer, EVP May 30, 2018 Sale $181.21 10,000 1,812,067 18,843 Jun 01, 2018, 08:14 AM
KING DAVID P President & CEO May 23, 2018 Option Exercise $84.86 49,966 4,240,115 271,635 May 25, 2018, 11:15 AM
KING DAVID P President & CEO May 23, 2018 Sale $175.37 49,966 8,762,352 227,069 May 25, 2018, 11:15 AM
KING DAVID P President & CEO Apr 23, 2018 Option Exercise $84.86 49,967 4,240,200 271,636 Apr 25, 2018, 04:59 PM
KING DAVID P President & CEO Apr 23, 2018 Sale $166.12 49,967 8,300,692 242,869 Apr 25, 2018, 04:59 PM
Gary M. Huff CEO, LabCorp Diagnostics Apr 04, 2018 Option Exercise $163.84 1,376 225,444 3,220 Apr 06, 2018, 09:39 AM
BERBERIAN LANCE SVP, Chief Information Officer Mar 29, 2018 Option Exercise $161.75 2,121 343,072 11,440 Apr 02, 2018, 11:54 AM
Dodson Edward T Principal Accounting Officer Mar 29, 2018 Option Exercise $161.75 1,600 258,800 9,113 Apr 02, 2018, 11:53 AM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 29, 2018 Option Exercise $161.75 2,152 348,086 28,062 Apr 02, 2018, 11:51 AM
EISENBERG GLENN A Chief Financial Officer, EVP Mar 29, 2018 Option Exercise $161.75 8,850 1,431,488 25,563 Apr 02, 2018, 11:50 AM
KING DAVID P President & CEO Mar 29, 2018 Option Exercise $161.75 33,015 5,340,176 221,669 Apr 02, 2018, 11:48 AM
Uthgenannt Lisa J Chief Human Resources Officer Mar 29, 2018 Option Exercise $161.75 2,828 457,429 8,255 Apr 02, 2018, 11:47 AM
KING DAVID P President & CEO Mar 23, 2018 Option Exercise $84.86 49,967 4,240,200 231,202 Mar 27, 2018, 09:03 AM
KING DAVID P President & CEO Mar 23, 2018 Sale $164.75 49,967 8,232,224 229,513 Mar 27, 2018, 09:03 AM
Dodson Edward T Principal Accounting Officer Mar 12, 2018 Option Exercise $175.61 111 19,493 5,861 Mar 14, 2018, 04:12 PM
KING DAVID P President & CEO Mar 12, 2018 Option Exercise $175.61 2,732 479,767 181,235 Mar 14, 2018, 03:47 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 12, 2018 Option Exercise $175.61 129 22,654 24,619 Mar 14, 2018, 03:38 PM
EISENBERG GLENN A Chief Financial Officer, EVP Mar 12, 2018 Option Exercise $175.61 732 128,547 14,726 Mar 14, 2018, 03:33 PM
BERBERIAN LANCE SVP, Chief Information Officer Mar 12, 2018 Option Exercise $175.61 120 21,073 8,709 Mar 14, 2018, 03:30 PM
Uthgenannt Lisa J Chief Human Resources Officer Mar 12, 2018 Option Exercise $175.61 184 32,312 4,590 Mar 14, 2018, 03:28 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 12, 2018 Sale $167.36 8,400 1,405,839 15,931 Feb 14, 2018, 02:32 PM
Ratliff John D CEO, Covance Drug Development Feb 09, 2018 Option Exercise $168.08 2,132 358,347 9,398 Feb 13, 2018, 02:08 PM
ANDERSON KERRII B Director Feb 09, 2018 Option Exercise $75.63 3,300 249,579 21,395 Feb 13, 2018, 01:58 PM
ANDERSON KERRII B Director Feb 09, 2018 Sale $166.10 3,300 548,123 18,095 Feb 13, 2018, 01:58 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 09, 2018 Option Exercise $168.08 1,462 245,733 22,231 Feb 13, 2018, 01:55 PM
BERBERIAN LANCE SVP, Chief Information Officer Feb 09, 2018 Option Exercise $168.08 1,048 176,148 8,429 Feb 13, 2018, 01:54 PM
Dodson Edward T Principal Accounting Officer Feb 09, 2018 Option Exercise $168.08 167 28,069 5,506 Feb 13, 2018, 01:51 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 09, 2018 Option Exercise $168.08 144 24,204 24,284 Feb 13, 2018, 01:47 PM
Uthgenannt Lisa J Chief Human Resources Officer Feb 09, 2018 Option Exercise $168.08 203 34,120 4,237 Feb 13, 2018, 01:46 PM
KING DAVID P President & CEO Feb 09, 2018 Option Exercise $168.08 3,138 527,435 177,890 Feb 13, 2018, 01:44 PM
Uthgenannt Lisa J Chief Human Resources Officer Feb 07, 2018 Option Exercise $169.66 129 21,886 3,837 Feb 09, 2018, 04:16 PM
KING DAVID P President & CEO Feb 07, 2018 Option Exercise $169.66 1,264 214,450 173,485 Feb 09, 2018, 04:13 PM
Ratliff John D CEO, Covance Drug Development Feb 07, 2018 Option Exercise $169.66 560 95,010 5,430 Feb 09, 2018, 04:11 PM
Gary M. Huff CEO, LabCorp Diagnostics Feb 07, 2018 Option Exercise $169.66 329 55,818 1,096 Feb 09, 2018, 04:09 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 07, 2018 Option Exercise $169.66 299 50,728 18,816 Feb 09, 2018, 04:05 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 07, 2018 Option Exercise $169.66 82 13,912 23,908 Feb 09, 2018, 04:02 PM
Dodson Edward T Principal Accounting Officer Feb 07, 2018 Option Exercise $169.66 92 15,609 5,223 Feb 09, 2018, 04:01 PM
BERBERIAN LANCE SVP, Chief Information Officer Feb 07, 2018 Option Exercise $169.66 105 17,814 5,980 Feb 09, 2018, 03:59 PM
Schechter Adam H Director Feb 08, 2018 Sale $169.29 1,263 213,813 6,034 Feb 09, 2018, 03:56 PM
BELINGARD JEAN-LUC Director Feb 07, 2018 Option Exercise $169.66 127 21,547 33,079 Feb 09, 2018, 03:47 PM
Gilliland Dwight Gary Director Oct 30, 2017 Sale $153.52 971 149,068 3,501 Nov 01, 2017, 10:31 AM
Gary M. Huff CEO, LabCorp Diagnostics Sep 01, 2017 Option Exercise $157.61 51 8,038 349 Oct 23, 2017, 04:10 PM
KING DAVID P President & CEO Sep 06, 2017 Option Exercise $90.74 44,687 4,054,898 258,753 Sep 07, 2017, 03:35 PM
KING DAVID P President & CEO Sep 06, 2017 Sale $156.86 44,687 7,009,789 221,566 Sep 07, 2017, 03:35 PM
KING DAVID P President & CEO Sep 05, 2017 Option Exercise $90.74 132,713 12,042,377 346,779 Sep 07, 2017, 09:18 AM
KING DAVID P President & CEO Sep 05, 2017 Sale $157.06 132,713 20,843,373 214,066 Sep 07, 2017, 09:18 AM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Aug 25, 2017 Option Exercise $69.12 31,500 2,177,239 55,194 Aug 29, 2017, 02:26 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Aug 25, 2017 Sale $155.22 31,500 4,889,461 23,694 Aug 29, 2017, 02:26 PM
Williams R Sanders Director Aug 11, 2017 Option Exercise $77.19 3,100 239,289 10,073 Aug 15, 2017, 03:03 PM
Williams R Sanders Director Aug 11, 2017 Sale $156.88 3,100 486,338 9,873 Aug 15, 2017, 03:03 PM
Dodson Edward T Principal Accounting Officer Aug 01, 2017 Sale $160.13 2,871 459,740 7,702 Aug 03, 2017, 04:35 PM
Uthgenannt Lisa J Chief Human Resources Officer Aug 01, 2017 Sale $160.00 5,000 800,000 3,622 Aug 03, 2017, 04:29 PM
EISENBERG GLENN A Chief Financial Officer, EVP Aug 01, 2017 Sale $159.46 5,968 951,669 18,122 Aug 03, 2017, 04:22 PM
EISENBERG GLENN A Chief Financial Officer, EVP Jun 16, 2017 Option Exercise $140.77 1,926 271,123 24,090 Jun 19, 2017, 02:48 PM
BERBERIAN LANCE SVP, Chief Information Officer May 22, 2017 Sale $139.85 3,613 505,260 5,789 May 24, 2017, 11:25 AM
BELINGARD JEAN-LUC Director May 09, 2017 Option Exercise $77.58 992 76,959 32,935 May 11, 2017, 08:17 AM
BELINGARD JEAN-LUC Director May 09, 2017 Sale $142.19 992 141,052 31,943 May 11, 2017, 08:17 AM
BERBERIAN LANCE SVP, Chief Information Officer Mar 29, 2017 Option Exercise $143.19 3,142 449,903 9,402 Mar 31, 2017, 01:50 PM
Dodson Edward T Principal Accounting Officer Mar 29, 2017 Option Exercise $143.19 2,850 408,092 7,754 Mar 31, 2017, 01:49 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 29, 2017 Option Exercise $143.19 3,212 459,926 23,694 Mar 31, 2017, 01:48 PM
EISENBERG GLENN A Chief Financial Officer, EVP Mar 29, 2017 Option Exercise $143.19 9,753 1,396,532 21,966 Mar 31, 2017, 01:47 PM
KING DAVID P President & CEO Mar 29, 2017 Option Exercise $143.19 48,596 6,958,461 198,359 Mar 31, 2017, 01:45 PM
Uthgenannt Lisa J Chief Human Resources Officer Mar 13, 2017 Option Exercise $144.24 3,654 527,053 8,803 Mar 14, 2017, 03:17 PM
BERBERIAN LANCE SVP, Chief Information Officer Mar 13, 2017 Option Exercise $144.24 132 19,040 5,789 Mar 14, 2017, 02:52 PM
Dodson Edward T Principal Accounting Officer Mar 13, 2017 Option Exercise $144.24 149 21,492 3,849 Mar 14, 2017, 02:44 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 13, 2017 Option Exercise $144.24 153 22,069 19,136 Mar 14, 2017, 02:43 PM
EISENBERG GLENN A Chief Financial Officer, EVP Mar 13, 2017 Option Exercise $144.24 774 111,642 11,209 Mar 14, 2017, 02:41 PM
KING DAVID P President & CEO Mar 13, 2017 Option Exercise $144.24 2,890 416,854 144,755 Mar 14, 2017, 02:39 PM
EISENBERG GLENN A Chief Financial Officer, EVP Mar 09, 2017 Sale $142.47 2,300 327,691 12,556 Mar 13, 2017, 09:34 AM
MITTELSTAEDT ROBERT E JR Director Feb 24, 2017 Option Exercise $75.63 5,300 400,839 18,208 Feb 27, 2017, 02:40 PM
MITTELSTAEDT ROBERT E JR Director Feb 24, 2017 Sale $142.69 5,300 756,256 18,008 Feb 27, 2017, 02:40 PM
ANDERSON KERRII B Director Feb 23, 2017 Option Exercise $76.60 1,992 152,589 16,832 Feb 27, 2017, 02:39 PM
ANDERSON KERRII B Director Feb 24, 2017 Option Exercise $75.63 1,000 75,630 16,832 Feb 27, 2017, 02:39 PM
ANDERSON KERRII B Director Feb 23, 2017 Sale $140.00 1,992 278,880 15,832 Feb 27, 2017, 02:39 PM
Dodson Edward T Principal Accounting Officer Feb 13, 2017 Option Exercise $134.93 182 24,557 3,598 Feb 14, 2017, 05:45 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 13, 2017 Option Exercise $134.93 206 27,796 18,826 Feb 14, 2017, 05:45 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 13, 2017 Option Exercise $134.93 552 74,481 12,656 Feb 14, 2017, 05:42 PM
BERBERIAN LANCE SVP, Chief Information Officer Feb 13, 2017 Option Exercise $134.93 489 65,981 5,703 Feb 14, 2017, 05:42 PM
KING DAVID P President & CEO Feb 13, 2017 Option Exercise $134.93 3,968 535,402 141,568 Feb 14, 2017, 05:42 PM
BERBERIAN LANCE SVP, Chief Information Officer Feb 13, 2017 Option Exercise $134.93 489 65,981 5,703 Feb 14, 2017, 05:40 PM
Uthgenannt Lisa J Chief Human Resources Officer Feb 09, 2017 Option Exercise $133.83 244 32,655 4,039 Feb 13, 2017, 02:40 PM
Dodson Edward T Principal Accounting Officer Feb 09, 2017 Option Exercise $133.83 138 18,469 3,230 Feb 13, 2017, 02:31 PM
Ratliff John D CEO, Covance Drug Development Feb 09, 2017 Option Exercise $133.83 2,013 269,400 4,127 Feb 13, 2017, 02:28 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 09, 2017 Option Exercise $133.83 188 25,160 18,398 Feb 13, 2017, 02:26 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 09, 2017 Option Exercise $133.83 1,610 215,466 11,534 Feb 13, 2017, 02:24 PM
BERBERIAN LANCE SVP, Chief Information Officer Feb 09, 2017 Option Exercise $133.83 1,171 156,715 4,530 Feb 13, 2017, 02:23 PM
KING DAVID P President & CEO Feb 09, 2017 Option Exercise $133.83 2,496 334,040 137,192 Feb 13, 2017, 02:21 PM
BELINGARD JEAN-LUC Director Feb 09, 2017 Option Exercise $133.83 156 20,877 31,943 Feb 13, 2017, 01:53 PM
Uthgenannt Lisa J Chief Human Resources Officer Aug 09, 2016 Sale $140.00 1,177 164,780 3,660 Aug 11, 2016, 07:57 AM
EISENBERG GLENN A Chief Financial Officer, EVP Aug 04, 2016 Sale $140.10 8,000 1,120,804 8,668 Aug 08, 2016, 02:58 PM
MITTELSTAEDT ROBERT E JR Director Aug 04, 2016 Option Exercise $77.58 992 76,959 12,340 Aug 08, 2016, 02:55 PM
MITTELSTAEDT ROBERT E JR Director Aug 04, 2016 Sale $140.15 992 139,027 11,348 Aug 08, 2016, 02:55 PM
EISENBERG GLENN A Chief Financial Officer, EVP Jun 16, 2016 Option Exercise $127.35 1,936 246,550 16,268 Jun 20, 2016, 10:38 AM
KING DAVID P President & CEO Jun 13, 2016 Option Exercise $70.15 196,400 13,777,460 271,210 Jun 15, 2016, 04:03 PM
KING DAVID P President & CEO Jun 13, 2016 Sale $128.00 196,400 25,139,088 197,755 Jun 15, 2016, 04:03 PM
Uthgenannt Lisa J Chief Human Resources Officer Apr 29, 2016 Sale $125.17 3,740 468,136 4,837 May 13, 2016, 04:03 PM
Dodson Edward T Principal Accounting Officer Apr 27, 2016 Sale $126.42 9,392 1,187,337 2,717 Apr 29, 2016, 09:01 AM
KING DAVID P President & CEO Mar 30, 2016 Option Exercise $117.85 48,425 5,706,886 147,371 Apr 01, 2016, 01:22 PM
EISENBERG GLENN A Chief Financial Officer, EVP Mar 30, 2016 Option Exercise $117.85 6,007 707,925 14,154 Apr 01, 2016, 01:21 PM
Dodson Edward T Principal Accounting Officer Mar 30, 2016 Option Exercise $117.85 2,349 276,830 12,109 Apr 01, 2016, 01:15 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 30, 2016 Option Exercise $117.85 2,466 290,618 22,285 Apr 01, 2016, 01:12 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 31, 2016 Sale $116.85 4,219 492,990 18,066 Apr 01, 2016, 01:12 PM
Boyle James T. Jr. EVP,CEO of LabCorp Diagnostics Mar 30, 2016 Option Exercise $117.85 16,605 1,956,899 41,586 Apr 01, 2016, 01:11 PM
Boyle James T. Jr. EVP,CEO of LabCorp Diagnostics Mar 31, 2016 Sale $116.81 18,132 2,118,030 28,395 Apr 01, 2016, 01:11 PM
BELINGARD JEAN-LUC Director Mar 11, 2016 Option Exercise $115.49 124 14,321 30,539 Mar 15, 2016, 03:35 PM
BERBERIAN LANCE SVP, Chief Information Officer Mar 11, 2016 Option Exercise $115.49 133 15,360 2,205 Mar 15, 2016, 01:45 PM
Dodson Edward T Principal Accounting Officer Mar 11, 2016 Option Exercise $115.49 124 14,321 7,773 Mar 15, 2016, 01:44 PM
EISENBERG GLENN A Chief Financial Officer, EVP Mar 11, 2016 Option Exercise $115.49 778 89,851 7,596 Mar 15, 2016, 01:42 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 11, 2016 Option Exercise $115.49 154 17,785 18,375 Mar 15, 2016, 01:41 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 14, 2016 Sale $115.32 309 35,634 18,066 Mar 15, 2016, 01:41 PM
Boyle James T. Jr. EVP,CEO of LabCorp Diagnostics Mar 11, 2016 Option Exercise $115.49 1,413 163,187 24,997 Mar 15, 2016, 01:39 PM
Boyle James T. Jr. EVP,CEO of LabCorp Diagnostics Mar 14, 2016 Sale $115.32 1,543 177,939 23,454 Mar 15, 2016, 01:39 PM
KING DAVID P President & CEO Mar 11, 2016 Option Exercise $115.49 2,905 335,498 94,489 Mar 15, 2016, 01:37 PM
Keller Deborah L CEO, Covance Drug Development Mar 11, 2016 Option Exercise $115.49 4,587 529,753 19,754 Mar 15, 2016, 01:36 PM
Uthgenannt Lisa J Chief Human Resources Officer Mar 11, 2016 Option Exercise $115.49 3,379 390,241 8,577 Mar 15, 2016, 01:34 PM
BELINGARD JEAN-LUC Director Feb 25, 2016 Option Exercise $59.37 1,296 76,944 30,722 Feb 29, 2016, 01:52 PM
BELINGARD JEAN-LUC Director Feb 25, 2016 Sale $109.74 1,296 142,225 30,504 Feb 29, 2016, 01:52 PM
Boyle James T. Jr. EVP,CEO of LabCorp Diagnostics Feb 16, 2016 Sale $103.02 4,055 417,746 25,614 Feb 18, 2016, 08:28 AM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 16, 2016 Sale $103.02 370 38,117 18,066 Feb 18, 2016, 08:27 AM
Boyle James T. Jr. EVP,CEO of LabCorp Diagnostics Feb 12, 2016 Option Exercise $103.02 2,116 217,990 27,509 Feb 16, 2016, 04:30 PM
Boyle James T. Jr. EVP,CEO of LabCorp Diagnostics Feb 11, 2016 Option Exercise $101.40 1,345 136,383 26,166 Feb 16, 2016, 04:30 PM
Boyle James T. Jr. EVP,CEO of LabCorp Diagnostics Feb 12, 2016 Sale $101.67 2,712 275,729 23,454 Feb 16, 2016, 04:30 PM
KING DAVID P President & CEO Feb 12, 2016 Option Exercise $103.02 3,735 384,780 91,318 Feb 16, 2016, 04:25 PM
KING DAVID P President & CEO Feb 11, 2016 Option Exercise $101.40 2,768 280,675 86,783 Feb 16, 2016, 04:25 PM
Dodson Edward T Principal Accounting Officer Feb 12, 2016 Option Exercise $103.02 182 18,750 7,497 Feb 16, 2016, 04:24 PM
Dodson Edward T Principal Accounting Officer Feb 11, 2016 Option Exercise $101.40 212 21,497 7,132 Feb 16, 2016, 04:24 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 12, 2016 Option Exercise $103.02 512 52,746 6,748 Feb 16, 2016, 04:23 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 11, 2016 Option Exercise $101.40 555 56,277 5,720 Feb 16, 2016, 04:23 PM
BERBERIAN LANCE SVP, Chief Information Officer Feb 11, 2016 Option Exercise $101.40 513 52,018 1,938 Feb 16, 2016, 04:22 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 12, 2016 Option Exercise $103.02 177 18,235 18,436 Feb 16, 2016, 04:21 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 11, 2016 Option Exercise $101.40 228 23,119 18,471 Feb 16, 2016, 04:21 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 12, 2016 Sale $101.67 405 41,176 18,066 Feb 16, 2016, 04:21 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Jan 08, 2016 Sale $119.05 1,215 144,646 18,066 Jan 12, 2016, 04:51 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Dec 08, 2015 Sale $123.31 1,010 124,543 19,281 Dec 10, 2015, 04:38 PM
Williams R Sanders Director Nov 02, 2015 Option Exercise $64.42 1,850 119,177 6,026 Nov 04, 2015, 03:20 PM
Williams R Sanders Director Nov 02, 2015 Sale $124.30 1,850 229,949 5,076 Nov 04, 2015, 03:20 PM
ANDERSON KERRII B Director Oct 29, 2015 Option Exercise $59.37 1,296 76,944 13,035 Nov 02, 2015, 02:31 PM
KING DAVID P President & CEO Aug 03, 2015 Option Exercise $80.37 50,000 4,018,500 131,153 Aug 05, 2015, 03:53 PM
KING DAVID P President & CEO Aug 03, 2015 Sale $127.93 50,000 6,396,358 97,453 Aug 05, 2015, 03:53 PM
HERRING JOSEPH L CEO of Covance Drug Division Jul 31, 2015 Option Exercise $127.29 9,586 1,220,202 10,404 Aug 04, 2015, 02:15 PM
KING DAVID P President & CEO Jul 01, 2015 Option Exercise $80.37 50,000 4,018,500 116,063 Jul 06, 2015, 09:08 PM
KING DAVID P President & CEO Jul 01, 2015 Sale $121.78 50,000 6,089,040 95,553 Jul 06, 2015, 09:08 PM
EISENBERG GLENN A Chief Financial Officer, EVP Jun 16, 2015 Option Exercise $120.48 1,596 192,286 4,602 Jun 18, 2015, 04:07 PM
KING DAVID P President & CEO Jun 01, 2015 Option Exercise $80.37 50,000 4,018,500 115,899 Jun 03, 2015, 04:17 PM
KING DAVID P President & CEO Jun 01, 2015 Sale $118.58 50,000 5,928,845 114,990 Jun 03, 2015, 04:17 PM
MITTELSTAEDT ROBERT E JR Director May 19, 2015 Option Exercise $59.37 1,296 76,944 11,407 May 21, 2015, 01:30 PM
MITTELSTAEDT ROBERT E JR Director May 19, 2015 Sale $119.02 1,296 154,254 11,007 May 21, 2015, 01:30 PM
Williams R Sanders Director May 11, 2015 Sale $118.05 965 113,914 4,678 May 14, 2015, 10:58 AM
BELINGARD JEAN-LUC Director Apr 29, 2015 Option Exercise $49.93 1,542 76,992 30,968 May 01, 2015, 05:14 PM
BELINGARD JEAN-LUC Director Apr 29, 2015 Sale $123.10 1,542 189,820 29,426 May 01, 2015, 05:14 PM
Boyle James T. Jr. EVP,CEO of LabCorp Diagnostics Apr 23, 2015 Sale $126.56 1,394 176,425 24,648 Apr 27, 2015, 05:28 PM
Brecher Mark E CMO, LabCorp Diagnostics Mar 30, 2015 Option Exercise $127.28 172 21,892 6,936 Apr 01, 2015, 08:35 PM
Brecher Mark E CMO, LabCorp Diagnostics Mar 30, 2015 Option Exercise $88.41 19,200 1,697,520 26,136 Apr 01, 2015, 08:35 PM
Brecher Mark E CMO, LabCorp Diagnostics Mar 31, 2015 Sale $127.00 347 44,069 5,511 Apr 01, 2015, 08:35 PM
Brecher Mark E CMO, LabCorp Diagnostics Mar 30, 2015 Sale $126.98 20,278 2,574,921 5,858 Apr 01, 2015, 08:35 PM
KING DAVID P President & CEO Mar 30, 2015 Option Exercise $127.28 3,974 505,811 65,899 Apr 01, 2015, 07:50 PM
Boyle James T. Jr. EVP,CEO of LabCorp Diagnostics Mar 30, 2015 Option Exercise $127.28 1,272 161,900 24,848 Apr 01, 2015, 07:48 PM
Dodson Edward T Principal Accounting Officer Mar 30, 2015 Option Exercise $127.28 172 21,892 6,575 Apr 01, 2015, 07:46 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 30, 2015 Option Exercise $127.28 172 21,892 20,291 Apr 01, 2015, 07:44 PM
Boyle James T. Jr. EVP, Chief Operating Officer Mar 02, 2015 Option Exercise $123.36 1,130 139,397 24,691 Mar 04, 2015, 10:38 AM
Boyle James T. Jr. EVP, Chief Operating Officer Mar 03, 2015 Sale $123.70 1,237 153,015 24,654 Mar 04, 2015, 10:38 AM
Dodson Edward T Principal Accounting Officer Mar 02, 2015 Option Exercise $123.36 154 18,997 6,228 Mar 04, 2015, 10:37 AM
Brecher Mark E Chief Medical Officer Mar 02, 2015 Option Exercise $123.36 154 18,997 6,589 Mar 04, 2015, 10:36 AM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 02, 2015 Option Exercise $123.36 155 19,121 19,944 Mar 04, 2015, 10:35 AM
KING DAVID P President & CEO Mar 02, 2015 Option Exercise $123.36 3,515 433,610 61,543 Mar 04, 2015, 10:33 AM
Williams R Sanders Director Feb 26, 2015 Sale $123.96 2,267 281,025 6,441 Mar 02, 2015, 04:26 PM
HERRING JOSEPH L CEO of Covance Drug Division Feb 25, 2015 Sale $121.64 36,876 4,485,436 6,158 Feb 27, 2015, 06:32 PM
Dodson Edward T Principal Accounting Officer Feb 12, 2015 Option Exercise $116.84 178 20,798 6,382 Feb 17, 2015, 04:06 PM
KING DAVID P President & CEO Feb 12, 2015 Option Exercise $116.84 3,945 460,934 65,058 Feb 17, 2015, 04:05 PM
Brecher Mark E Chief Medical Officer Feb 12, 2015 Option Exercise $116.84 177 20,681 6,743 Feb 17, 2015, 04:01 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 12, 2015 Option Exercise $116.84 178 20,798 20,099 Feb 17, 2015, 03:58 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 12, 2015 Option Exercise $116.84 510 59,588 2,148 Feb 17, 2015, 03:57 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 12, 2015 Option Exercise $116.84 2,287 267,213 29,704 Feb 17, 2015, 03:55 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 13, 2015 Sale $116.66 3,883 452,991 27,807 Feb 17, 2015, 03:55 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 12, 2015 Sale $116.71 2,714 316,751 25,821 Feb 17, 2015, 03:55 PM
Dodson Edward T Principal Accounting Officer Feb 11, 2015 Option Exercise $116.73 212 24,747 6,013 Feb 13, 2015, 05:44 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 11, 2015 Option Exercise $116.73 1,342 156,652 28,535 Feb 13, 2015, 05:10 PM
Brecher Mark E Chief Medical Officer Feb 11, 2015 Option Exercise $116.73 213 24,863 6,373 Feb 13, 2015, 04:54 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 11, 2015 Option Exercise $116.73 228 26,614 19,730 Feb 13, 2015, 04:44 PM
EISENBERG GLENN A Chief Financial Officer, EVP Feb 11, 2015 Option Exercise $116.73 555 64,785 1,118 Feb 13, 2015, 04:40 PM
KING DAVID P President & CEO Feb 11, 2015 Option Exercise $116.73 3,262 380,773 60,733 Feb 13, 2015, 04:39 PM
BELINGARD JEAN-LUC Director Feb 10, 2015 Option Exercise $115.39 151 17,424 29,426 Feb 12, 2015, 04:07 PM
KING DAVID P President & CEO Sep 22, 2014 Option Exercise $75.63 65,234 4,933,647 120,817 Sep 24, 2014, 11:44 AM
KING DAVID P President & CEO Sep 22, 2014 Sale $104.71 65,234 6,830,741 60,283 Sep 24, 2014, 11:44 AM
Williams R Sanders Director Sep 05, 2014 Sale $107.95 2,000 215,906 6,505 Sep 09, 2014, 03:35 PM
KING DAVID P President & CEO Aug 22, 2014 Option Exercise $75.63 65,233 4,933,572 120,816 Aug 26, 2014, 02:38 PM
KING DAVID P President & CEO Aug 22, 2014 Sale $106.10 65,233 6,921,482 55,583 Aug 26, 2014, 02:38 PM
KING DAVID P President & CEO Jul 22, 2014 Option Exercise $75.63 65,233 4,933,572 120,816 Jul 24, 2014, 04:43 PM
KING DAVID P President & CEO Jul 22, 2014 Sale $105.55 65,233 6,885,411 57,183 Jul 24, 2014, 04:43 PM
Boyle James T. Jr. EVP, Chief Operating Officer Jun 09, 2014 Option Exercise $84.86 38,600 3,275,596 64,421 Jun 10, 2014, 04:25 PM
Boyle James T. Jr. EVP, Chief Operating Officer Jun 09, 2014 Sale $103.00 38,600 3,975,800 25,821 Jun 10, 2014, 04:25 PM
Hayes William B Chief Financial Officer, EVP Jun 06, 2014 Option Exercise $88.36 47,367 4,185,380 66,767 Jun 10, 2014, 04:24 PM
Hayes William B Chief Financial Officer, EVP Jun 06, 2014 Sale $104.23 47,367 4,936,965 41,500 Jun 10, 2014, 04:24 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Jun 06, 2014 Option Exercise $60.04 10,000 600,400 29,325 Jun 10, 2014, 04:12 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Jun 06, 2014 Sale $104.37 10,000 1,043,700 19,325 Jun 10, 2014, 04:12 PM
Brecher Mark E Chief Medical Officer Jun 04, 2014 Sale $102.31 2,600 266,006 5,754 Jun 06, 2014, 02:53 PM
Williams R Sanders Director May 08, 2014 Option Exercise $98.96 1,593 157,643 7,905 May 12, 2014, 05:11 PM
Rubenstein Arthur H Director May 08, 2014 Option Exercise $98.96 1,593 157,643 11,772 May 12, 2014, 05:10 PM
Schechter Adam H Director May 08, 2014 Option Exercise $98.96 1,593 157,643 1,734 May 12, 2014, 05:07 PM
NEUPERT PETER M Director May 08, 2014 Option Exercise $98.96 1,593 157,643 2,168 May 12, 2014, 05:05 PM
MITTELSTAEDT ROBERT E JR Director May 08, 2014 Option Exercise $98.96 1,593 157,643 8,608 May 12, 2014, 05:04 PM
LANE WENDY E Director May 08, 2014 Option Exercise $98.96 1,593 157,643 18,988 May 12, 2014, 05:03 PM
BELINGARD JEAN-LUC Director May 08, 2014 Option Exercise $98.96 160 15,834 28,074 May 12, 2014, 05:00 PM
BELINGARD JEAN-LUC Director May 08, 2014 Option Exercise $98.96 1,593 157,643 28,234 May 12, 2014, 05:00 PM
ANDERSON KERRII B Director May 08, 2014 Option Exercise $98.96 1,593 157,643 10,236 May 12, 2014, 04:56 PM
WEIKEL M KEITH Director May 08, 2014 Option Exercise $98.96 1,593 157,643 13,958 May 09, 2014, 03:35 PM
WEIKEL M KEITH Director May 07, 2014 Option Exercise $38.80 1,984 76,979 14,349 May 09, 2014, 03:35 PM
WEIKEL M KEITH Director May 07, 2014 Sale $98.28 1,984 194,979 13,248 May 09, 2014, 03:35 PM
BELINGARD JEAN-LUC Director Apr 30, 2014 Option Exercise $38.80 1,984 76,979 28,625 May 02, 2014, 05:13 PM
BELINGARD JEAN-LUC Director Apr 30, 2014 Sale $98.68 1,984 195,782 28,525 May 02, 2014, 05:13 PM
Hayes William B Chief Financial Officer, EVP Apr 30, 2014 Sale $98.39 2,497 245,680 19,400 May 02, 2014, 05:12 PM
LANE WENDY E Director Apr 30, 2014 Option Exercise $38.80 992 38,490 17,785 May 02, 2014, 05:11 PM
LANE WENDY E Director Apr 30, 2014 Sale $98.97 390 38,599 17,395 May 02, 2014, 05:11 PM
MITTELSTAEDT ROBERT E JR Director Apr 30, 2014 Option Exercise $43.67 3,526 153,971 8,999 May 02, 2014, 05:10 PM
MITTELSTAEDT ROBERT E JR Director Apr 30, 2014 Sale $98.39 3,526 346,923 7,015 May 02, 2014, 05:10 PM
Boyle James T. Jr. EVP, Chief Operating Officer Mar 27, 2014 Option Exercise $97.87 2,304 225,492 28,342 Mar 31, 2014, 03:55 PM
Boyle James T. Jr. EVP, Chief Operating Officer Mar 28, 2014 Sale $98.36 2,521 247,966 25,821 Mar 31, 2014, 03:55 PM
Brecher Mark E Chief Medical Officer Mar 27, 2014 Option Exercise $97.87 329 32,199 8,354 Mar 31, 2014, 03:53 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 27, 2014 Option Exercise $97.87 329 32,199 19,325 Mar 31, 2014, 03:52 PM
Hayes William B Chief Financial Officer, EVP Mar 27, 2014 Option Exercise $97.87 2,283 223,437 21,897 Mar 31, 2014, 03:51 PM
KING DAVID P President & CEO Mar 27, 2014 Option Exercise $97.87 7,193 703,979 70,147 Mar 31, 2014, 03:50 PM
Hayes William B Chief Financial Officer, EVP Mar 07, 2014 Option Exercise $84.86 19,166 1,626,427 38,566 Mar 10, 2014, 08:57 AM
Hayes William B Chief Financial Officer, EVP Mar 06, 2014 Sale $94.00 4,682 440,119 23,802 Mar 10, 2014, 08:57 AM
Hayes William B Chief Financial Officer, EVP Mar 07, 2014 Sale $94.50 19,166 1,811,187 19,400 Mar 10, 2014, 08:57 AM
Boyle James T. Jr. EVP, Chief Operating Officer Mar 03, 2014 Sale $93.06 1,582 147,221 25,821 Mar 10, 2014, 08:54 AM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 28, 2014 Option Exercise $93.54 785 73,429 27,403 Mar 04, 2014, 02:00 PM
Brecher Mark E Chief Medical Officer Feb 28, 2014 Option Exercise $93.54 151 14,125 7,691 Mar 04, 2014, 01:58 PM
Hayes William B Chief Financial Officer, EVP Feb 28, 2014 Option Exercise $93.54 774 72,400 24,082 Mar 04, 2014, 01:57 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 28, 2014 Option Exercise $93.54 151 14,125 18,662 Mar 04, 2014, 01:55 PM
KING DAVID P President & CEO Feb 28, 2014 Option Exercise $93.54 3,518 329,074 62,277 Mar 04, 2014, 01:53 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 12, 2014 Option Exercise $90.98 2,046 186,145 32,311 Feb 14, 2014, 07:29 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 13, 2014 Sale $90.29 4,123 372,266 30,416 Feb 14, 2014, 07:29 PM
KING DAVID P President & CEO Feb 12, 2014 Option Exercise $90.98 3,949 359,280 65,795 Feb 13, 2014, 07:39 PM
Brecher Mark E Chief Medical Officer Feb 12, 2014 Option Exercise $90.98 194 17,650 7,842 Feb 13, 2014, 07:36 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 12, 2014 Option Exercise $90.98 184 16,740 18,813 Feb 13, 2014, 07:34 PM
Hayes William B Chief Financial Officer, EVP Feb 12, 2014 Option Exercise $90.98 934 84,975 24,856 Feb 13, 2014, 07:30 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 10, 2014 Option Exercise $91.35 142 12,972 18,451 Feb 12, 2014, 03:40 PM
Brecher Mark E Chief Medical Officer Feb 10, 2014 Option Exercise $91.35 142 12,972 7,490 Feb 12, 2014, 03:30 PM
Hayes William B Chief Financial Officer, EVP Feb 10, 2014 Option Exercise $91.35 600 54,810 22,974 Feb 12, 2014, 03:28 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 10, 2014 Option Exercise $91.35 596 54,445 29,392 Feb 12, 2014, 03:27 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 11, 2014 Sale $91.15 1,204 109,745 28,188 Feb 12, 2014, 03:27 PM
KING DAVID P President & CEO Feb 10, 2014 Option Exercise $91.35 2,225 203,254 61,474 Feb 12, 2014, 03:22 PM
KING DAVID P President & CEO Jan 27, 2014 Option Exercise $60.04 24,200 1,452,968 87,899 Jan 29, 2014, 03:18 PM
KING DAVID P President & CEO Jan 27, 2014 Sale $90.15 24,200 2,181,637 63,699 Jan 29, 2014, 03:18 PM
KING DAVID P President & CEO Dec 24, 2013 Option Exercise $60.04 25,000 1,501,000 88,628 Dec 27, 2013, 04:50 PM
KING DAVID P President & CEO Dec 24, 2013 Sale $90.79 25,000 2,269,750 63,628 Dec 27, 2013, 04:50 PM
Brecher Mark E Chief Medical Officer Nov 25, 2013 Sale $105.62 400 42,248 7,585 Nov 27, 2013, 10:59 AM
KING DAVID P President & CEO Nov 25, 2013 Option Exercise $60.04 25,000 1,501,000 88,628 Nov 27, 2013, 09:55 AM
KING DAVID P President & CEO Nov 25, 2013 Sale $106.01 25,000 2,650,300 63,628 Nov 27, 2013, 09:55 AM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Nov 11, 2013 Option Exercise $58.57 10,000 585,700 28,593 Nov 13, 2013, 01:54 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Nov 11, 2013 Sale $105.83 10,000 1,058,350 18,593 Nov 13, 2013, 01:54 PM
KING DAVID P President & CEO Oct 24, 2013 Option Exercise $60.04 25,000 1,501,000 88,628 Oct 28, 2013, 09:14 AM
KING DAVID P President & CEO Oct 24, 2013 Sale $100.91 25,000 2,522,801 68,041 Oct 28, 2013, 09:14 AM
Boyle James T. Jr. EVP, Chief Operating Officer Oct 17, 2013 Option Exercise $77.57 24,400 1,892,772 44,388 Oct 21, 2013, 02:59 PM
Boyle James T. Jr. EVP, Chief Operating Officer Oct 17, 2013 Sale $102.00 24,400 2,488,800 29,988 Oct 21, 2013, 02:59 PM
KING DAVID P President & CEO Sep 25, 2013 Option Exercise $60.04 25,000 1,501,000 88,628 Sep 27, 2013, 10:45 AM
KING DAVID P President & CEO Sep 25, 2013 Sale $99.06 25,000 2,476,615 63,628 Sep 27, 2013, 10:45 AM
KING DAVID P President & CEO Aug 26, 2013 Option Exercise $60.04 25,000 1,501,000 88,628 Aug 28, 2013, 12:01 PM
KING DAVID P President & CEO Aug 26, 2013 Sale $96.60 25,000 2,415,047 63,628 Aug 28, 2013, 12:01 PM
MITTELSTAEDT ROBERT E JR Director Aug 21, 2013 Sale $96.86 7,429 719,592 14,244 Aug 23, 2013, 10:09 AM
KING DAVID P President & CEO Jul 24, 2013 Option Exercise $60.04 25,000 1,501,000 88,628 Jul 26, 2013, 03:56 PM
KING DAVID P President & CEO Jul 24, 2013 Sale $97.72 25,000 2,442,897 63,628 Jul 26, 2013, 03:56 PM
KING DAVID P President & CEO Jun 24, 2013 Option Exercise $60.04 25,000 1,501,000 88,423 Jun 26, 2013, 05:38 PM
KING DAVID P President & CEO Jun 24, 2013 Sale $98.66 25,000 2,466,533 64,123 Jun 26, 2013, 05:38 PM
Boyle James T. Jr. EVP, Chief Operating Officer Jun 07, 2013 Option Exercise $70.15 63,100 4,426,465 93,088 Jun 11, 2013, 02:19 PM
Boyle James T. Jr. EVP, Chief Operating Officer Jun 07, 2013 Sale $99.63 63,100 6,286,653 29,988 Jun 11, 2013, 02:19 PM
Brecher Mark E Chief Medical Officer May 28, 2013 Option Exercise $70.15 14,900 1,045,235 24,653 May 30, 2013, 04:34 PM
Brecher Mark E Chief Medical Officer May 28, 2013 Sale $100.92 16,900 1,705,548 7,753 May 30, 2013, 04:34 PM
BELINGARD JEAN-LUC Director May 24, 2013 Option Exercise $100.37 60 6,022 26,641 May 29, 2013, 04:35 PM
Hayes William B Chief Financial Officer, EVP May 21, 2013 Option Exercise $77.68 127,200 9,880,836 95,774 May 23, 2013, 04:05 PM
Hayes William B Chief Financial Officer, EVP May 21, 2013 Sale $100.00 127,200 12,720,000 23,574 May 23, 2013, 04:05 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary May 17, 2013 Option Exercise $47.89 10,000 478,900 28,593 May 21, 2013, 05:26 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary May 17, 2013 Sale $98.47 10,000 984,700 18,593 May 21, 2013, 05:26 PM
BELINGARD JEAN-LUC Director May 13, 2013 Option Exercise $95.01 54 5,131 26,701 May 15, 2013, 05:03 PM
Boyle James T. Jr. EVP, Chief Operating Officer May 10, 2013 Option Exercise $59.13 60,734 3,591,261 98,896 May 14, 2013, 04:37 PM
Boyle James T. Jr. EVP, Chief Operating Officer May 10, 2013 Sale $93.82 68,908 6,464,866 29,988 May 14, 2013, 04:37 PM
BELINGARD JEAN-LUC Director May 08, 2013 Option Exercise $30.36 2,536 76,993 29,291 May 10, 2013, 07:56 AM
BELINGARD JEAN-LUC Director May 08, 2013 Sale $92.88 2,536 235,544 26,755 May 10, 2013, 07:56 AM
WEIKEL M KEITH Director May 03, 2013 Option Exercise $31.35 2,046 64,142 14,411 May 06, 2013, 12:35 PM
WEIKEL M KEITH Director May 03, 2013 Sale $92.91 2,046 190,086 12,965 May 06, 2013, 12:35 PM
LANE WENDY E Director Apr 29, 2013 Option Exercise $93.73 412 38,617 16,831 May 01, 2013, 03:37 PM
LANE WENDY E Director Apr 29, 2013 Option Exercise $30.36 1,268 38,496 17,205 May 01, 2013, 03:37 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Apr 25, 2013 Sale $93.84 1,500 140,760 18,593 Apr 29, 2013, 03:49 PM
Williams R Sanders Director Apr 24, 2013 Option Exercise $64.42 1,850 119,177 8,162 Apr 25, 2013, 01:13 PM
Williams R Sanders Director Apr 24, 2013 Sale $93.77 1,850 173,477 6,932 Apr 25, 2013, 01:13 PM
Hayes William B Chief Financial Officer, EVP Apr 11, 2013 Option Exercise $70.15 22,234 1,559,715 45,808 Apr 15, 2013, 03:37 PM
Hayes William B Chief Financial Officer, EVP Apr 11, 2013 Sale $95.00 22,234 2,112,230 23,574 Apr 15, 2013, 03:37 PM
KING DAVID P President & CEO Mar 28, 2013 Option Exercise $90.20 17,180 1,549,636 63,423 Apr 01, 2013, 03:47 PM
Fonseca Lidia Chief Information Officer Mar 28, 2013 Option Exercise $90.20 872 78,654 9,087 Apr 01, 2013, 03:45 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 28, 2013 Option Exercise $90.20 872 78,654 20,093 Apr 01, 2013, 03:44 PM
Hayes William B Chief Financial Officer, EVP Mar 28, 2013 Option Exercise $90.20 5,580 503,316 28,523 Apr 01, 2013, 03:43 PM
Brecher Mark E Chief Medical Officer Mar 28, 2013 Option Exercise $90.20 903 81,451 9,753 Apr 01, 2013, 03:41 PM
Boyle James T. Jr. EVP, Chief Operating Officer Mar 28, 2013 Option Exercise $90.20 5,484 494,657 38,162 Apr 01, 2013, 03:32 PM
KING DAVID P President & CEO Feb 28, 2013 Option Exercise $88.60 3,533 313,024 44,776 Mar 04, 2013, 02:32 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 28, 2013 Option Exercise $88.60 790 69,994 32,171 Mar 04, 2013, 02:30 PM
Hayes William B Chief Financial Officer, EVP Feb 28, 2013 Option Exercise $88.60 779 69,019 21,974 Mar 04, 2013, 02:29 PM
Brecher Mark E Chief Medical Officer Feb 28, 2013 Option Exercise $88.60 156 13,822 7,951 Mar 04, 2013, 02:27 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 28, 2013 Option Exercise $88.60 156 13,822 18,353 Mar 04, 2013, 02:26 PM
Fonseca Lidia Chief Information Officer Feb 28, 2013 Option Exercise $88.60 156 13,822 7,347 Mar 04, 2013, 02:24 PM
KING DAVID P President & CEO Feb 11, 2013 Option Exercise $90.06 4,115 370,597 50,292 Feb 13, 2013, 05:17 PM
Brecher Mark E Chief Medical Officer Feb 11, 2013 Option Exercise $90.06 322 28,999 8,235 Feb 13, 2013, 05:15 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 11, 2013 Option Exercise $90.06 310 27,919 18,638 Feb 13, 2013, 05:10 PM
Fonseca Lidia Chief Information Officer Feb 11, 2013 Option Exercise $90.06 310 27,919 7,632 Feb 13, 2013, 05:06 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 11, 2013 Option Exercise $90.06 1,298 116,898 33,562 Feb 13, 2013, 05:04 PM
Hayes William B Chief Financial Officer, EVP Feb 11, 2013 Option Exercise $90.06 1,325 119,329 23,343 Feb 13, 2013, 05:03 PM
MAC MAHON THOMAS P Director Sep 06, 2012 Sale $89.74 35,000 3,141,044 32,297 Sep 10, 2012, 11:10 AM
MITTELSTAEDT ROBERT E JR Director Aug 27, 2012 Option Exercise $30.36 2,536 76,993 16,980 Aug 29, 2012, 03:01 PM
MITTELSTAEDT ROBERT E JR Director Aug 27, 2012 Sale $88.61 2,536 224,715 14,444 Aug 29, 2012, 03:01 PM
Brecher Mark E Chief Medical Officer Jul 13, 2012 Option Exercise $60.04 19,200 1,152,768 28,716 Jul 17, 2012, 03:05 PM
Brecher Mark E Chief Medical Officer Jul 13, 2012 Sale $95.00 20,341 1,932,395 9,516 Jul 17, 2012, 03:05 PM
Fonseca Lidia Chief Information Officer Jul 13, 2012 Option Exercise $60.04 18,200 1,092,728 26,013 Jul 17, 2012, 03:02 PM
Fonseca Lidia Chief Information Officer Jul 13, 2012 Sale $95.00 18,200 1,729,000 7,813 Jul 17, 2012, 03:02 PM
KING DAVID P President & CEO Jul 09, 2012 Option Exercise $59.43 84,800 5,039,942 195,032 Jul 11, 2012, 02:54 PM
KING DAVID P President & CEO Jul 09, 2012 Sale $92.11 84,800 7,810,928 110,232 Jul 11, 2012, 02:54 PM
Fonseca Lidia Chief Information Officer Jun 27, 2012 Sale $90.00 1,687 151,830 7,813 Jun 29, 2012, 03:36 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Jun 04, 2012 Sale $83.83 2,678 224,504 19,119 Jun 06, 2012, 05:08 PM
BELINGARD JEAN-LUC Director May 14, 2012 Option Exercise $85.33 30 2,560 24,955 May 15, 2012, 01:41 PM
BELINGARD JEAN-LUC Director May 11, 2012 Option Exercise $86.72 24 2,081 24,985 May 15, 2012, 01:41 PM
LANE WENDY E Director May 09, 2012 Option Exercise $48.02 677 32,510 14,480 May 11, 2012, 02:36 PM
LANE WENDY E Director May 09, 2012 Sale $85.98 510 43,851 14,470 May 11, 2012, 02:36 PM
LANE WENDY E Director May 08, 2012 Option Exercise $64.42 617 39,747 14,587 May 10, 2012, 09:37 AM
LANE WENDY E Director May 08, 2012 Sale $86.46 800 69,170 14,070 May 10, 2012, 09:37 AM
BELINGARD JEAN-LUC Director May 07, 2012 Option Exercise $87.04 37 3,220 25,009 May 09, 2012, 10:46 AM
BELINGARD JEAN-LUC Director May 01, 2012 Option Exercise $48.02 1,353 64,971 26,399 May 03, 2012, 03:39 PM
BELINGARD JEAN-LUC Director May 01, 2012 Sale $88.11 1,353 119,218 26,151 May 03, 2012, 03:39 PM
Walton Andrew Scott EVP Apr 09, 2012 Sale $91.82 4,000 367,280 24,298 Apr 11, 2012, 02:57 PM
Boyle James T. Jr. EVP, Chief Operating Officer Mar 26, 2012 Option Exercise $91.90 8,315 764,149 37,320 Mar 28, 2012, 04:35 PM
KING DAVID P President & CEO Mar 26, 2012 Option Exercise $91.90 27,690 2,544,711 153,784 Mar 28, 2012, 04:31 PM
Hayes William B Chief Financial Officer, EVP Mar 26, 2012 Option Exercise $91.90 10,137 931,590 37,819 Mar 28, 2012, 04:23 PM
Hayes William B Chief Financial Officer, EVP Mar 26, 2012 Option Exercise $70.15 2,750 192,913 26,828 Mar 28, 2012, 04:23 PM
Hayes William B Chief Financial Officer, EVP Mar 27, 2012 Sale $91.67 13,741 1,259,587 24,078 Mar 28, 2012, 04:23 PM
Hayes William B Chief Financial Officer, EVP Mar 26, 2012 Sale $90.00 2,750 247,500 24,078 Mar 28, 2012, 04:23 PM
Walton Andrew Scott EVP Mar 26, 2012 Option Exercise $91.90 4,999 459,408 26,298 Mar 28, 2012, 04:22 PM
Brecher Mark E Chief Medical Officer Mar 26, 2012 Option Exercise $91.90 1,607 147,683 9,286 Mar 28, 2012, 04:17 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 26, 2012 Option Exercise $91.90 1,559 143,272 21,497 Mar 28, 2012, 04:16 PM
Fonseca Lidia Chief Information Officer Mar 26, 2012 Option Exercise $91.90 1,559 143,272 9,500 Mar 28, 2012, 04:15 PM
Hayes William B Chief Financial Officer, EVP Mar 23, 2012 Option Exercise $65.89 72,083 4,749,612 100,648 Mar 27, 2012, 03:58 PM
Hayes William B Chief Financial Officer, EVP Mar 23, 2012 Sale $89.68 76,570 6,866,831 83,941 Mar 27, 2012, 03:58 PM
MAC MAHON THOMAS P Director Feb 29, 2012 Sale $89.98 60,000 5,398,812 65,497 Mar 02, 2012, 03:26 PM
Walton Andrew Scott EVP Feb 10, 2012 Option Exercise $90.03 466 41,954 17,221 Feb 13, 2012, 03:38 PM
Walton Andrew Scott EVP Feb 09, 2012 Option Exercise $92.11 726 66,872 18,001 Feb 13, 2012, 03:38 PM
Hayes William B Chief Financial Officer, EVP Feb 10, 2012 Option Exercise $90.03 888 79,947 21,565 Feb 13, 2012, 03:37 PM
Hayes William B Chief Financial Officer, EVP Feb 09, 2012 Option Exercise $92.11 1,292 119,006 23,027 Feb 13, 2012, 03:37 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 10, 2012 Option Exercise $90.03 466 41,954 15,888 Feb 13, 2012, 03:36 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 09, 2012 Option Exercise $92.11 1,268 116,795 16,939 Feb 13, 2012, 03:36 PM
KING DAVID P President & CEO Feb 10, 2012 Option Exercise $90.03 3,170 285,395 94,146 Feb 13, 2012, 03:36 PM
KING DAVID P President & CEO Feb 09, 2012 Option Exercise $92.11 4,721 434,851 99,679 Feb 13, 2012, 03:36 PM
Fonseca Lidia Chief Information Officer Feb 09, 2012 Option Exercise $92.11 296 27,265 5,153 Feb 13, 2012, 03:34 PM
Fonseca Lidia Chief Information Officer Feb 10, 2012 Option Exercise $90.03 174 15,665 4,855 Feb 13, 2012, 03:34 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 10, 2012 Option Exercise $90.03 174 15,665 17,072 Feb 13, 2012, 03:34 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 09, 2012 Option Exercise $92.11 296 27,265 17,370 Feb 13, 2012, 03:34 PM
Brecher Mark E Chief Medical Officer Feb 10, 2012 Option Exercise $90.03 184 16,566 4,543 Feb 13, 2012, 03:33 PM
Brecher Mark E Chief Medical Officer Feb 09, 2012 Option Exercise $92.11 751 69,175 5,294 Feb 13, 2012, 03:33 PM
KING DAVID P President & CEO Jan 25, 2012 Option Exercise $58.57 20,000 1,171,400 122,037 Jan 27, 2012, 04:09 PM
KING DAVID P President & CEO Jan 25, 2012 Sale $92.00 20,000 1,840,000 102,037 Jan 27, 2012, 04:09 PM
KING DAVID P President & CEO Dec 02, 2011 Option Exercise $47.89 20,000 957,800 121,957 Dec 06, 2011, 02:57 PM
KING DAVID P President & CEO Dec 02, 2011 Sale $88.00 20,000 1,760,000 101,957 Dec 06, 2011, 02:57 PM
MITTELSTAEDT ROBERT E JR Director Aug 18, 2011 Option Exercise $48.02 1,353 64,971 12,925 Aug 22, 2011, 01:51 PM
MITTELSTAEDT ROBERT E JR Director Aug 18, 2011 Sale $79.96 817 65,329 12,108 Aug 22, 2011, 01:51 PM
Williams R Sanders Director May 19, 2011 Option Exercise $75.94 6,292 477,798 9,812 May 23, 2011, 01:01 PM
Williams R Sanders Director May 19, 2011 Sale $100.73 6,292 633,769 8,912 May 23, 2011, 01:01 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary May 13, 2011 Option Exercise $78.75 15,200 1,196,976 32,742 May 17, 2011, 03:10 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary May 13, 2011 Sale $99.04 15,200 1,505,479 17,542 May 17, 2011, 03:10 PM
BELINGARD JEAN-LUC Director May 12, 2011 Option Exercise $100.00 30 3,000 25,046 May 13, 2011, 05:23 PM
BELINGARD JEAN-LUC Director May 11, 2011 Option Exercise $34.25 1,896 64,938 26,272 May 13, 2011, 05:23 PM
BELINGARD JEAN-LUC Director May 11, 2011 Sale $98.79 1,896 187,298 25,172 May 13, 2011, 05:23 PM
BELINGARD JEAN-LUC Director May 09, 2011 Option Exercise $98.48 30 2,954 24,376 May 10, 2011, 03:35 PM
BELINGARD JEAN-LUC Director May 06, 2011 Option Exercise $97.59 37 3,611 24,406 May 10, 2011, 03:35 PM
LANE WENDY E Director Apr 25, 2011 Option Exercise $96.10 339 32,579 13,453 Apr 27, 2011, 04:04 PM
LANE WENDY E Director Apr 25, 2011 Option Exercise $34.25 948 32,469 13,792 Apr 27, 2011, 04:04 PM
KING DAVID P President & CEO Apr 25, 2011 Sale $95.86 7,254 695,368 101,765 Apr 27, 2011, 04:03 PM
Brecher Mark E Chief Medical Officer Apr 21, 2011 Sale $98.00 1,271 124,558 5,828 Apr 22, 2011, 11:23 AM
MAC MAHON THOMAS P Director Apr 14, 2011 Option Exercise $58.57 71,133 4,166,260 175,930 Apr 18, 2011, 03:10 PM
MAC MAHON THOMAS P Director Apr 15, 2011 Option Exercise $58.57 103,867 6,083,490 208,664 Apr 18, 2011, 03:10 PM
MAC MAHON THOMAS P Director Apr 15, 2011 Sale $95.97 83,867 8,048,482 130,797 Apr 18, 2011, 03:10 PM
MAC MAHON THOMAS P Director Apr 14, 2011 Sale $95.00 71,133 6,757,855 104,797 Apr 18, 2011, 03:10 PM
Walton Andrew Scott EVP Apr 14, 2011 Sale $95.00 1,535 145,825 18,413 Apr 18, 2011, 03:08 PM
Walton Andrew Scott EVP Apr 11, 2011 Sale $92.69 1,536 142,372 19,948 Apr 13, 2011, 02:50 PM
Walton Andrew Scott EVP Mar 30, 2011 Option Exercise $91.57 1,780 162,995 21,484 Apr 01, 2011, 05:14 PM
Boyle James T. Jr. EVP, Chief Operating Officer Mar 30, 2011 Option Exercise $91.57 780 71,425 17,622 Apr 01, 2011, 05:13 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Mar 30, 2011 Option Exercise $91.57 597 54,667 17,542 Apr 01, 2011, 05:12 PM
Fonseca Lidia Chief Information Officer Mar 30, 2011 Option Exercise $91.57 597 54,667 5,325 Apr 01, 2011, 05:11 PM
KING DAVID P President & CEO Mar 30, 2011 Option Exercise $91.57 10,702 979,982 109,019 Apr 01, 2011, 05:09 PM
Hayes William B Chief Financial Officer, EVP Mar 30, 2011 Option Exercise $91.57 3,963 362,892 29,116 Apr 01, 2011, 05:08 PM
Hayes William B Chief Financial Officer, EVP Mar 31, 2011 Sale $91.21 5,371 489,866 23,745 Apr 01, 2011, 05:08 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 14, 2011 Option Exercise $87.73 141 12,370 16,302 Feb 16, 2011, 03:33 PM
Hayes William B Chief Financial Officer, EVP Feb 14, 2011 Option Exercise $87.73 892 78,255 24,953 Feb 16, 2011, 03:30 PM
Hayes William B Chief Financial Officer, EVP Feb 15, 2011 Sale $87.45 1,208 105,640 23,745 Feb 16, 2011, 03:30 PM
Walton Andrew Scott EVP Feb 14, 2011 Option Exercise $87.73 357 31,320 18,413 Feb 16, 2011, 03:27 PM
KING DAVID P President & CEO Feb 14, 2011 Option Exercise $87.73 2,435 213,623 94,511 Feb 16, 2011, 03:23 PM
Fonseca Lidia Chief Information Officer Feb 14, 2011 Option Exercise $87.73 141 12,370 4,085 Feb 16, 2011, 03:19 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 14, 2011 Option Exercise $87.73 141 12,370 16,565 Feb 16, 2011, 03:18 PM
Hayes William B Chief Financial Officer, EVP Feb 11, 2011 Sale $87.18 1,846 160,934 25,845 Feb 15, 2011, 12:08 PM
Hayes William B Chief Financial Officer, EVP Feb 09, 2011 Option Exercise $90.74 718 65,151 24,726 Feb 11, 2011, 05:46 PM
Hayes William B Chief Financial Officer, EVP Feb 10, 2011 Option Exercise $87.73 887 77,817 58,058 Feb 11, 2011, 05:46 PM
Hayes William B Chief Financial Officer, EVP Feb 10, 2011 Option Exercise $60.04 30,367 1,823,235 58,945 Feb 11, 2011, 05:46 PM
Hayes William B Chief Financial Officer, EVP Feb 10, 2011 Sale $88.18 31,815 2,805,425 30,591 Feb 11, 2011, 05:46 PM
KING DAVID P President & CEO Feb 10, 2011 Option Exercise $87.73 2,692 236,169 96,946 Feb 11, 2011, 05:16 PM
KING DAVID P President & CEO Feb 09, 2011 Option Exercise $90.74 2,077 188,467 82,938 Feb 11, 2011, 05:16 PM
Conrad Andrew J EVP, Chief Scientific Officer Feb 09, 2011 Option Exercise $90.74 496 45,007 27,055 Feb 11, 2011, 05:13 PM
Conrad Andrew J EVP, Chief Scientific Officer Feb 10, 2011 Option Exercise $87.73 514 45,093 26,541 Feb 11, 2011, 05:13 PM
Brecher Mark E Chief Medical Officer Feb 10, 2011 Option Exercise $87.73 184 16,142 6,749 Feb 11, 2011, 04:40 PM
Brecher Mark E Chief Medical Officer Feb 09, 2011 Option Exercise $90.74 1,075 97,545 2,624 Feb 11, 2011, 04:40 PM
Walton Andrew Scott EVP Feb 10, 2011 Option Exercise $87.73 466 40,882 18,770 Feb 11, 2011, 04:40 PM
Walton Andrew Scott EVP Feb 09, 2011 Option Exercise $90.74 412 37,385 16,336 Feb 11, 2011, 04:40 PM
Fonseca Lidia Chief Information Officer Feb 10, 2011 Option Exercise $87.73 178 15,616 4,226 Feb 11, 2011, 04:36 PM
Fonseca Lidia Chief Information Officer Feb 09, 2011 Option Exercise $90.74 171 15,517 3,304 Feb 11, 2011, 04:36 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 10, 2011 Option Exercise $87.73 466 40,882 16,706 Feb 11, 2011, 04:30 PM
Boyle James T. Jr. EVP, Chief Operating Officer Feb 09, 2011 Option Exercise $90.74 685 62,157 11,772 Feb 11, 2011, 04:30 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 10, 2011 Option Exercise $87.73 178 15,616 16,443 Feb 11, 2011, 04:28 PM
EBERTS F SAMUEL III Chief Legal Officer, Secretary Feb 09, 2011 Option Exercise $90.74 171 15,517 15,521 Feb 11, 2011, 04:28 PM
Hayes William B Chief Financial Officer, EVP Dec 27, 2010 Option Exercise $60.04 30,366 1,823,175 55,810 Dec 28, 2010, 02:04 PM
Hayes William B Chief Financial Officer, EVP Dec 27, 2010 Sale $87.95 30,366 2,670,702 25,444 Dec 28, 2010, 02:04 PM
MAC MAHON THOMAS P Director Dec 01, 2010 Option Exercise $47.89 175,000 8,380,750 259,797 Dec 03, 2010, 09:21 AM
MAC MAHON THOMAS P Director Dec 01, 2010 Sale $85.00 155,000 13,175,000 104,797 Dec 03, 2010, 09:21 AM
Walton Andrew Scott EVP Oct 29, 2010 Sale $81.00 881 71,361 16,748 Nov 02, 2010, 05:16 PM
Walton Andrew Scott EVP Oct 29, 2010 Sale $81.00 881 71,361 16,748 Nov 02, 2010, 05:16 PM
Walton Andrew Scott EVP Oct 29, 2010 Sale $81.00 881 71,361 16,748 Nov 02, 2010, 08:27 AM
Walton Andrew Scott EVP Oct 29, 2010 Sale $81.00 881 71,361 16,748 Nov 02, 2010, 08:27 AM
Hayes William B Chief Financial Officer, EVP Oct 13, 2010 Option Exercise $58.57 30,000 1,757,100 55,444 Oct 15, 2010, 02:45 PM
Hayes William B Chief Financial Officer, EVP Oct 13, 2010 Sale $80.00 30,000 2,400,000 25,444 Oct 15, 2010, 02:45 PM
Walton Andrew Scott EVP Oct 06, 2010 Option Exercise $58.57 5,000 292,850 22,629 Oct 08, 2010, 04:15 PM
Walton Andrew Scott EVP Oct 06, 2010 Sale $79.50 5,000 397,500 17,629 Oct 08, 2010, 04:15 PM
Walton Andrew Scott EVP Oct 01, 2010 Sale $79.00 881 69,599 17,629 Oct 05, 2010, 04:54 PM
Walton Andrew Scott EVP Oct 01, 2010 Sale $79.00 881 69,599 17,629 Oct 05, 2010, 04:54 PM
MITTELSTAEDT ROBERT E JR Director Sep 08, 2010 Option Exercise $34.25 1,896 64,938 13,304 Sep 10, 2010, 10:31 AM
MITTELSTAEDT ROBERT E JR Director Sep 08, 2010 Sale $74.32 1,896 140,906 13,204 Sep 10, 2010, 10:31 AM
Conrad Andrew J EVP, Chief Scientific Officer Jul 26, 2010 Buy $74.32 6,100 453,347 6,100 Jul 30, 2010, 11:07 AM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Schroeder Mark S EVP, President-Diagnostics Lab 11/08/2022 259,660
Schroeder Mark S EVP, President-Diagnostics Lab 11/07/2022 208,990
Caveney Brian J EVP, President of Diagnostics 11/07/2022 208,990
EISENBERG GLENN A Chief Financial Officer, EVP 11/01/2022 1,190,251
Schechter Adam H President & CEO 11/01/2022 198,746
Kirchgraber Paul R CEO, Covance Drug Development 11/01/2022 198,524
EISENBERG GLENN A Chief Financial Officer, EVP 09/26/2022 5,265,576
Caveney Brian J EVP, President of Diagnostics 09/07/2022 10,173
EISENBERG GLENN A Chief Financial Officer, EVP 08/03/2022 4,722,543
EISENBERG GLENN A Chief Financial Officer, EVP 08/03/2022 8,151,450
Wilkinson Peter J SVP, Chief Accounting Officer 08/01/2022 5,933
Wilkinson Peter J SVP, Chief Accounting Officer 08/01/2022 112,435
Wilkinson Peter J SVP, Chief Accounting Officer 08/01/2022 665,635
Caveney Brian J EVP, President of Diagnostics 06/07/2022 10,172
Schroeder Mark S EVP, President-Diagnostics Lab 03/29/2022 652,871
van der Vaart Sandra D EVP, Chief Legal Officer 03/29/2022 678,642
BERBERIAN LANCE EVP, CIO & CTO 03/28/2022 652,351
Caveney Brian J EVP, President of Diagnostics 03/28/2022 520,499
EISENBERG GLENN A Chief Financial Officer, EVP 03/28/2022 1,737,576
Kirchgraber Paul R CEO, Covance Drug Development 03/28/2022 455,540
Schroeder Mark S EVP, President-Diagnostics Lab 03/28/2022 521,052
van der Vaart Sandra D EVP, Chief Legal Officer 03/28/2022 495,345
Wilkinson Peter J SVP, Chief Accounting Officer 03/28/2022 252,924
Williams R Sanders Director 03/25/2022 156,145
Summy Amy B. EVP, Chief Marketing Officer 03/10/2022 65,290
NEUPERT PETER M Director 02/16/2022 922,815
Schroeder Mark S EVP, President-Diagnostics Lab 02/15/2022 56,714
van der Vaart Sandra D EVP, Chief Legal Officer 02/15/2022 56,714
Wilkinson Peter J SVP, Chief Accounting Officer 02/14/2022 71,169
Caveney Brian J EVP, President of Diagnostics 02/14/2022 212,145
EISENBERG GLENN A Chief Financial Officer, EVP 02/14/2022 75,532
Kirchgraber Paul R CEO, Covance Drug Development 02/14/2022 29,449
BERBERIAN LANCE EVP, CIO & CTO 02/14/2022 217,871
Schroeder Mark S EVP, President-Diagnostics Lab 02/14/2022 20,996
van der Vaart Sandra D EVP, Chief Legal Officer 02/14/2022 20,996
BERBERIAN LANCE EVP, CIO & CTO 02/04/2022 30,245
Caveney Brian J EVP, President of Diagnostics 02/04/2022 45,784
EISENBERG GLENN A Chief Financial Officer, EVP 02/04/2022 79,359
Kirchgraber Paul R CEO, Covance Drug Development 02/04/2022 45,784
Schechter Adam H President & CEO 02/04/2022 391,802
Schroeder Mark S EVP, President-Diagnostics Lab 02/04/2022 42,177
Schroeder Mark S EVP, President-Diagnostics Lab 02/07/2022 56,586
Seltz Judith C EVP, CHRO 02/04/2022 23,586
Summy Amy B. EVP, Chief Marketing Officer 02/04/2022 23,031
van der Vaart Sandra D EVP, Chief Legal Officer 02/04/2022 22,753
van der Vaart Sandra D EVP, Chief Legal Officer 02/07/2022 60,469
Wilkinson Peter J SVP, Chief Accounting Officer 02/04/2022 14,706
Schroeder Mark S EVP, President-Diagnostics Lab 02/02/2022 33,055
Schroeder Mark S EVP, President-Diagnostics Lab 02/03/2022 43,761
van der Vaart Sandra D EVP, Chief Legal Officer 02/02/2022 17,484
van der Vaart Sandra D EVP, Chief Legal Officer 02/03/2022 46,751
Summy Amy B. EVP, Chief Marketing Officer 02/02/2022 21,035
Kirchgraber Paul R CEO, Covance Drug Development 02/02/2022 39,338
Seltz Judith C EVP, CHRO 02/02/2022 20,762
Wilkinson Peter J SVP, Chief Accounting Officer 02/02/2022 11,200
Caveney Brian J EVP, President of Diagnostics 02/02/2022 40,157
Schechter Adam H President & CEO 02/02/2022 219,364
EISENBERG GLENN A Chief Financial Officer, EVP 02/02/2022 64,470
BERBERIAN LANCE EVP, CIO & CTO 02/02/2022 28,138
BELINGARD JEAN-LUC Director 02/02/2022 21,308
Gilliland Dwight Gary Director 12/15/2021 151,128
Caveney Brian J EVP, President of Diagnostics 11/05/2021 247,081
Schroeder Mark S EVP, President-Diagnostics Lab 11/05/2021 247,081
Schechter Adam H President & CEO 11/01/2021 255,859
EISENBERG GLENN A Chief Financial Officer, EVP 11/01/2021 1,164,939
Kirchgraber Paul R CEO, Covance Drug Development 11/01/2021 259,324
van der Vaart Sandra D EVP, Chief Legal Officer 09/15/2021 381,870
van der Vaart Sandra D EVP, Chief Legal Officer 09/15/2021 1,335,510
Wilkinson Peter J SVP, Chief Accounting Officer 08/02/2021 4,464
van der Vaart Sandra D EVP, Chief Legal Officer 06/07/2021 381,870
van der Vaart Sandra D EVP, Chief Legal Officer 06/07/2021 1,199,520
BELINGARD JEAN-LUC Director 05/03/2021 256,074
BELINGARD JEAN-LUC Director 05/03/2021 699,803
Kirchgraber Paul R CEO, Covance Drug Development 04/03/2021 114,207
Schroeder Mark S EVP, President-Diagnostics Lab 03/30/2021 168,004
van der Vaart Sandra D EVP, Chief Legal Officer 03/30/2021 204,527
EISENBERG GLENN A Chief Financial Officer, EVP 03/27/2021 904,430
BERBERIAN LANCE EVP, CIO & CTO 03/27/2021 271,455
Caveney Brian J EVP, President of Diagnostics 03/27/2021 271,455
Kirchgraber Paul R CEO, Covance Drug Development 03/27/2021 198,748
Schroeder Mark S EVP, President-Diagnostics Lab 03/27/2021 271,455
van der Vaart Sandra D EVP, Chief Legal Officer 03/27/2021 172,835
Wilkinson Peter J SVP, Chief Accounting Officer 02/12/2021 62,662
Wilkinson Peter J SVP, Chief Accounting Officer 02/18/2021 340,251
Wilkinson Peter J SVP, Chief Accounting Officer 02/18/2021 559,589
van der Vaart Sandra D EVP, Chief Legal Officer 02/12/2021 37,645
van der Vaart Sandra D EVP, Chief Legal Officer 02/16/2021 49,202
Schroeder Mark S EVP, President-Diagnostics Lab 02/12/2021 33,833
Schroeder Mark S EVP, President-Diagnostics Lab 02/16/2021 44,567
Kirchgraber Paul R CEO, Covance Drug Development 02/12/2021 42,887
EISENBERG GLENN A Chief Financial Officer, EVP 02/12/2021 121,989
Caveney Brian J EVP, President of Diagnostics 02/12/2021 203,474
BERBERIAN LANCE EVP, CIO & CTO 02/12/2021 208,001
Schechter Adam H President & CEO 02/04/2021 230,046
Wilkinson Peter J SVP, Chief Accounting Officer 02/04/2021 11,860
van der Vaart Sandra D EVP, Chief Legal Officer 02/04/2021 18,574
van der Vaart Sandra D EVP, Chief Legal Officer 02/05/2021 24,618
Summy Amy B. EVP, Chief Marketing Officer 02/04/2021 21,035
Schroeder Mark S EVP, President-Diagnostics Lab 02/04/2021 34,462
Schroeder Mark S EVP, President-Diagnostics Lab 02/05/2021 45,848
Kirchgraber Paul R CEO, Covance Drug Development 02/04/2021 41,847
EISENBERG GLENN A Chief Financial Officer, EVP 02/04/2021 68,477
Caveney Brian J EVP, President of Diagnostics 02/04/2021 42,518
BERBERIAN LANCE EVP, CIO & CTO 02/04/2021 29,315
Seltz Judith C EVP, CHRO 02/04/2021 21,483
BELINGARD JEAN-LUC Director 02/04/2021 22,154
Williams R Sanders Director 01/26/2021 128,037
Schroeder Mark S EVP, President-Diagnostics Lab 11/06/2020 126,179
Caveney Brian J EVP, President of Diagnostics 11/05/2020 189,976
Schroeder Mark S EVP, President-Diagnostics Lab 11/05/2020 179,041
Kirchgraber Paul R CEO, Covance Drug Development 11/04/2020 321,204
EISENBERG GLENN A Chief Financial Officer, EVP 11/02/2020 835,966
Schechter Adam H President & CEO 11/02/2020 183,399
Kirchgraber Paul R CEO, Covance Drug Development 11/02/2020 185,471
Caveney Brian J EVP, President of Diagnostics 09/25/2020 52,306
Williams R Sanders Director 07/08/2020 128,037
Williams R Sanders Director 07/08/2020 225,056
van der Vaart Sandra D EVP, Chief Legal Officer 07/02/2020 73,950
van der Vaart Sandra D EVP, Chief Legal Officer 06/24/2020 139,808
KING DAVID P Director 05/05/2020 5,000,000
Seltz Judith C EVP, CHRO 03/10/2020 55,625
Seltz Judith C EVP, CHRO 02/28/2020 43,735
Kirchgraber Paul R CEO, Covance Drug Development 04/03/2020 42,151
KING DAVID P Director 03/30/2020 3,243,727
van der Vaart Sandra D EVP, Chief Legal Officer 03/30/2020 145,937
EISENBERG GLENN A Chief Financial Officer, EVP 03/30/2020 763,595
Kirchgraber Paul R CEO, Covance Drug Development 03/30/2020 133,797
Schroeder Mark S EVP, President-Diagnostics Lab 03/30/2020 152,138
BERBERIAN LANCE EVP, CIO & CTO 03/30/2020 223,655
Wilkinson Peter J SVP, Chief Accounting Officer 02/21/2020 56,326
BELINGARD JEAN-LUC Director 02/19/2020 239,289
BELINGARD JEAN-LUC Director 02/19/2020 5,024,750
EISENBERG GLENN A Chief Financial Officer, EVP 02/12/2020 96,005
van der Vaart Sandra D SVP, Global General Counsel 02/12/2020 29,627
van der Vaart Sandra D SVP, Global General Counsel 02/13/2020 39,206
Schroeder Mark S EVP, President-Diagnostics Lab 02/12/2020 26,626
Schroeder Mark S EVP, President-Diagnostics Lab 02/13/2020 35,436
BERBERIAN LANCE SVP, Chief Information Officer 02/12/2020 163,509
Caveney Brian J EVP, President of Diagnostics 02/12/2020 162,384
Wilkinson Peter J SVP, Chief Accounting Officer 02/12/2020 51,003
Kirchgraber Paul R CEO, Covance Drug Development 02/12/2020 29,814
KING DAVID P Director